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ABSTRACT: An application of a one-pot sequential
Vilsmeier−Haack cyclization and intramolecular azomethine
ylide 1,3-dipolar cycloaddition toward the total synthesis of
(±)-caldaphnidine C is presented. It allowed an efficient
formation of three cycles with perfect control of four of the
five newly created stereogenic centers including one all-carbon
quaternary center. Two synthetic strategies to produce the
key-step precursor, the investigation and optimization of the
cyclization partners (nucleophile, azomethine ylide, and
dipolarophile), and further derivatization of the cycloadduct
are reported.
■ INTRODUCTION
Some of the most architecturally complex and synthetically
challenging alkaloid natural products are found in the
Daphniphyllum family.1 Several impressive syntheses of many
members of the 14 different types of Daphniphyllum alkaloids
have been reported over the years,2 but daphnilactone B-type
and yuzurimine-type alkaloids still resist the efforts of synthetic
chemists. These alkaloids share the same rigid and compact
tetracyclic core 1 that could be regarded as a common synthetic
intermediate to many alkaloids of these types (Figure 1).
So far, only five research groups have reported synthetic
approaches toward members of daphnilactone B-type and
yuzurimine-type alkaloids.3 The group of Denmark used a
cascade of intramolecular hetero-Diels−Alder and nitronate
cycloadditions approach, followed by reductive amination to
assemble the tricyclic core 4 of these alkaloids in 27 steps
(Scheme 1, top left).4 It should be noted that this approach is
nonracemic and that the two contiguous quaternary centers
(C3 and C4) were set in the key step. Hayakawa and Kigoshi
reported last year a radical cyclization with compound 6 to set
the tetracarbocyclic core 7 of yuzurimine-type alkaloids
(Scheme 1, bottom left).5 In a model study, the group of
Coldham used a cascade of condensation of aldehyde 8 with
ethyl glycinate, intramolecular imine alkylation, and azomethine
ylide cycloaddition to build the bridged bicyclic portion 9 of the
natural products (Scheme 1, top right).6 Through a Dieckman
cyclization and decarboxylation sequence, the group of
Hanessian assembled the seven-membered ring and completed
four of the five cycles of daphnilactone B-type alkaloids from
compound 10 (Scheme 1, middle right).7 Finally, our group
developed one-pot sequential cyclizations to access four of the
five rings common to daphnilactone B-type and yuzurimine-
type alkaloids (see 13, Scheme 1, bottom right).8 Herein, we
report a full account of this synthetic approach, with an
extensive study of the key step, as well as our efforts to install
proper functionalization on the polycyclic adduct in a premise
to the completion of the total synthesis of caldaphnidine C.
■ RESULTS AND DISCUSSION
We embarked on this journey with the goal to prepare the
common intermediate 1 depicted in Figure 1 that should allow
the synthesis of both daphnilactone B-type and yuzurimine-
type Daphniphyllum alkaloids. We felt that this common
intermediate could be accessed using a new synthetic strategy
we developed in our group,9 namely, a sequential Vilsmeier−
Haack cyclization and intramolecular azomethine ylide 1,3-
dipolar cycloaddition as shown in Scheme 2. This one-pot
process allows the formation of three cycles of the tetracyclic
core, with perfect control of four of the five newly generated
stereogenic centers, the fifth one being destroyed later on.
Additionally, adduct 1 bears proper functional groups to further
advance toward the targeted alkaloids. The substrate for the key
transformation is a cycloheptane ring 14 bearing an amide
branch, a nucleophilic (Nü) alkene, and a dipolarophile branch
(alkene).
We anticipated several challenges with this approach. First,
the seven-membered ring key-step substrate 14 requires a cis
relationship between the amide and the dipolarophile branches,
which may be hard to control on conformationally flexible
seven-membered rings (Scheme 2). Secondly, with such a
densely functionalized substrate, chemoselectivity in the amide
activation, as well as for all ensuing steps, could rapidly become
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an issue. Thirdly, the transition state for the Vilsmeier−Haack
cyclization is a chairlike conformation with three of the four
substituents on the chair axially oriented. We could, therefore,
anticipate a low concentration of the reactive conformation,
usually translated in a low reaction rate and ultimately in low
yield. This raised the question about the stability of
triflyliminium ion 15 in these conditions. Fourthly, the
Figure 1. Representative daphnilactone B-type and yuzurimine-type
Daphniphyllum alkaloids.
Scheme 1. Efforts toward the Total Synthesis of Daphnilactone B-Type and Yuzurimine-Type Daphniphyllum Alkaloids
Scheme 2. Key Step and Challenges toward Common
Intermediate 1
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Vilsmeier−Haack cyclization will generate a congested
quaternary center (C1), adjacent to another quaternary center
(C14). Fifthly, after the generation of the azomethine ylide 17,
the intramolecular 1,3-dipolar cycloaddition will create a
bridged system with three new stereogenic centers. Regio-
and diastereoselectivity will be controlled mainly by conforma-
tional restrictions imposed by the intramolecularity of the
process. To maximize our chances of success in using this key
transformation for the synthesis of daphnilactone B-type and
yuzurimine-type alkaloids, we addressed each of these
challenges separately with model systems.
First Model Study: Generation of a Quaternary Center
in the Vilsmeier−Haack Cyclization. As an initial study, we
decided to concentrate our efforts on the generation of the
quaternary center in the Vilsmeier−Haack cyclization (Scheme
3). We opted to design a model compound 20 lacking the
quaternary center at C14 and functionalization on the amide to
prepare the azomethine ylide. We hoped to confirm this first
step in the sequence after reduction of the transient iminium
ion 19. The key-step precursor 20 would be obtained after the
installation of an allylsilane, the nucleophile chosen for this first
study. Side chains would be incorporated on cycloheptanone in
a cis relationship through 1,4-addition and alkylation reactions.
The synthesis of compound 20 started with the trans-
esterification of known methyl ester 22 using allyl alcohol
(Scheme 4).10 After alkylation with 4-bromobutene, treatment
of allyl β-ketoester 24 in oxidative deallyloxycarbonylation
conditions11 using Pd2(dba)3 generated a 1:1 mixture of endo
and exo enones 25 and 26, respectively. Fortunately, careful
separation of these isomers led to the isolation of pure endo
enone 25 that was used in the next steps. A Mukaiyama−
Michael addition of silyl ketene acetal 2712 in the presence of
TiCl4,
13 followed by kinetic protonation of the resulting enolate
at low temperature with acetic acid, produced a 3.4:1 mixture of
two hardly separable diastereomers 28 and 29. Unfortunately,
we have not been able to prove the relative stereochemistry
beyond any doubt,14 but related examples in the literature on
five- and six-membered rings present a good selectivity for cis
isomers.12 One-pot addition of vinylmagnesium bromide to
ketone, trapping of the resulting alcoholate with ethyl
chloroformate, and SN2′ displacement of the allylcarbonate
with silyl organocuprate (PhMe2Si)2CuCNLi2 gave allylsilane
29 in good yield. Only the major diastereomer 28 reacted in
these conditions. Saponification of tert-butyl ester 30, followed
by Curtius rearrangement,15 reduction of the resulting
isocyanate,16 and formylation using Katritzky reagent, N-
formylbenzotriazole,17 furnished compound 20 in 71% yield
over four steps.
At this point, installation of the quaternary center and
preparation of the bridged azabicyclo[4.3.1]decane unit 18
using the intramolecular Vilsmeier−Haack cyclization was
tested (Scheme 5). We planned to reduce the iminium ion
19 in situ to be able to isolate and characterize the product.
Although the activation of formamide 20 with triflic anhydride
in the presence of 2,6-di-t-butyl-4-methylpyridine (DTBMP)
gave triflyliminium ion 32, no cyclization was observed at room
temperature. Pushing the conditions to refluxing 1,2-dichloro-
Scheme 3. Retrosynthetic Analysis of Model Compound 18
Scheme 4. Synthesis of the Vilsmeier−Haack Cyclization Precursor 20 with Allylsilane
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ethane (DCE) resulted in a quite unusual cyclization: after
iminium reduction, cycloadduct 35 was obtained, correspond-
ing to an unexpected regioselectivity for the reaction of the
allylsilane. Facing the steric constraint due to the generation of
the quaternary center in the anticipated adduct 19, the
allylsilane reacted with the least nucleophilic site (β to Si) to
generate a tertiary center as in 33. This result convinced us that
the allylsilane was not nucleophilic enough for the Vilsmeier−
Haack cyclization on substrate 20 and stronger carbon
nucleophiles are needed in order to force the generation of
the hindered quaternary carbon.
The choice of a silyl enol ether as a stronger nucleophile was
obvious.18 Installation of the latter was performed on a mixture
of ketones 28 and 29 synthesized in the first model study.
Hence, a Wittig olefination afforded methyl enol ether 36
(Scheme 6).19 Unlike the case for the installation of the
allylsilane, this time, both diastereomers 28 and 29 reacted and
a mixture of four partially separable isomers of 36 was obtained.
The next steps up to compound 38 followed the sequence
previously developed. Hydrolysis of methyl enol ether 38,20,21
followed by enolization of aldehyde 39 with tert-butyldimethyl-
silyl trifluoromethanesulfonate (TBDMSOTf), afforded silyl
enol ether 40.22,23
Upon activation of formamide 40 with triflic anhydride, the
intramolecular Vilsmeier−Haack reaction proceeded smoothly
at room temperature over 18 h. Triflyliminium ion 41 can even
be observed by 1H NMR considering the slow rate of the
cyclization, and refluxing conditions were necessary to get a
complete conversion to iminium ion 42 (Scheme 7). The latter
was reduced in situ with NaBH4 to provide bicyclic compound
43 in an unoptimized 48% yield. Surprisingly, the aldehyde was
not reduced. This result definitely confirmed the possibility to
create a quaternary center during the formation of the
piperidine ring using a silyl enol ether as the nucleophile in
the intramolecular Vilsmeier−Haack reaction.
Second Model Study: Preparation of the Azomethine
Ylide and Intramolecular 1,3-Dipolar Cycloaddition. The
next objective of this study was to evaluate the feasibility of the
second cyclization, a 1,3-dipolar cycloaddition. The most direct
route to daphnilactone B congeners was to opt for an
unstabilized azomethine ylide (R″ = SiMe3 or SnBu3, Scheme
2) as a dipole since the latter leads to a methylene β to nitrogen
in the pyrrolidine ring, as in the natural products.24 As shown in
Scheme 8, a Curtius rearrangement on the previously
synthesized carboxylic acid 37 and treatment of the resulting
isocycanate with 9-fluorenemethanol in the presence of Ti(O-t-
Bu)4 furnished N-Fmoc protected amine 44 in good yield (92%
over 3 steps).25 Formamide 45 was obtained following
deprotection of the Fmoc group with NaH, in situ alkylation
Scheme 5. Vilsmeier−Haack Cyclization with Allylsilane 20
Scheme 6. Synthesis of the Vilsmeier−Haack Cyclization
Precursor 40 with Silyl Enol Ether
Scheme 7. Vilsmeier−Haack Cyclization with Silyl Enol
Ether 40
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of the sodium amide with iodomethyltrimethylsilane, and
formylation17 in 60% overall yield. Hydrolysis of the methyl
enol ether 45 was more problematic, and previous conditions
(2 N HCl) failed probably due to the sensitivity of the
trimethylsilyl group to acidic conditions and to chloride anions.
Diluted aqueous trichloroacetic acid worked best, and aldehyde
46 was obtained in good yield (82%).26 Finally, enolization22 of
the latter furnished the compound 47 that was then tested in
the full cyclization sequence.
Formamide 47 was activated with triflic anhydride in the
presence of DTBMP, and after 3 h at 50 °C, a complete
Vilsmeier−Haack cyclization was observed by 1H NMR
(Scheme 9). However, when a source chloride was added to
N-trimethylsilylmethyliminium ion 49 to promote desilylation
and generation of the unstabilized azomethine ylide 50, no
cycloadduct 51 was obtained. To verify the formation and
reactivity of azomethine ylide 50, addition of an excess of an
external dipolarophile such as dimethyl acetylenedicarboxylate
(DMAD) or N-phenylmaleimide, using tetrabutylammonium
chloride (TBAC) or tetrabutylammonium triphenyldifluoro-
silicate (TBAT) to promote desilylation also failed to produce
the expected cycloadducts 54 or 55, respectively. In all cases,
only aldehyde 46 was recovered after workup. We postulated
that there was a reversible addition of halide to the iminium ion
49 which resulted in a retro-Mannich reaction, thus releasing
ring strain in the bridged bicyclic system of 52, to produce
aldehyde 46 as the sole isolated product.
At this point, two possible solutions were envisaged to
circumvent this reactivity issue and favor conversion of the
cascade precursor to the desired tetracyclic adduct. The first
one was to weaken the carbon−metal bond in compound 47 by
replacing silicon with tin.9b,27 This way, the demetalation rate
should increase28 and the desired azomethine ylide 50 may be
formed and trapped prior to any addition to the iminium ion
and retro-Mannich reaction. Unfortunately, the carbon−tin
bond is too labile and incorporation of a stannane at different
points in the synthesis never led to the desired tin-containing
key-step precursor.
The second solution was to avoid the use of a nucleophile to
generate the azomethine ylide. Instead, the latter would be
prepared by deprotonation α to the iminium nitrogen on a
substrate bearing an electron-withdrawing group (cf. 49, Me3Si
= nitrile or ester). However, additional steps are expected to
cleave off this electron-withdrawing group after the cyclo-
addition since no substitution is present in the natural products
on methylene β to nitrogen in the pyrrolidine ring. As shown in
Scheme 10, installation of a nitrile group was performed on
Scheme 8. Synthesis of Cyclization Precursor 47 with Silyl
Enol Ether
Scheme 9. Attempted Key Sequential Cyclizations with Silyl Enol Ether 47
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intermediate 44 and the same subsequent reaction sequence
was applied.
Formamide 59 was treated with triflic anhydride, and
formation of triflyliminium ion 60 was confirmed by 1H
NMR (Scheme 11). Hunig’s base (i-Pr2NEt) was then added to
generate the corresponding stabilized azomethine ylide, but the
desired cycloadduct 61 was observed only in traces by 1H NMR
spectrometry on the crude material. This result may be
explained by one or more of the following three plausible
hypotheses. (1) The nitrile was not compatible with the
activation conditions. (2) The major isomer obtained from the
1,4-addition of silyl ketene acetal 27 to heptenone 25, followed
by a kinetic protonation (Scheme 4), was not the cis isomer 28
leading to 59 as expected but rather the trans product 29
leading to 62 (Scheme 11). The latter could not undergo
intramolecular cycloaddition because the butenyl side chain
would point in the wrong direction (cf. 63). (3) The terminal
alkene was not activated enough to react with the stabilized
azomethine ylide.29
Compatibility of the nitrile in the key cyclization sequence
was tested on model substrate 65 prepared straightforwardly
from known formamide 64 (Scheme 12).9a Alkylation with
bromoacetonitrile was not optimal but nonetheless furnished
enough material to test our hypothesis. Iminium 66 was
observed after treatment of formamide 65 with triflic anhydride
without affecting the nitrile group. The ensuing azomethine
ylide formation and 1,3-dipolar cycloaddition with N-phenyl-
maleimide produced cycloadduct 67 in good yield (69%) as a
mixture of four diastereomers. Compatibility of the nitrile
group in this sequence of cyclization was thus demonstrated,
and the unsuccessful key sequential cyclizations of Scheme 11
could only be explained by the wrong trans diastereomer (cf.
62) and/or the lack of reactivity of the terminal alkene in the
cycloaddition.
To address both of these issues, a completely new synthesis
of the key reaction substrate was designed. The route will
unequivocally establish the correct and needed relative
stereochemistry between the amide and the dipolarophile. It
will also allow modulation of the dipolarophile reactivity:
according to the work of Coldham, a dramatic increase in
reactivity (lower temperature and higher yield) is observed for
stabilized azomethine ylide cycloadditions when an ester-
substituted alkene is used as the dipolarophile instead of a
nonsubstituted terminal alkene.29
Third Model Study: Preparation of an Azomethine
Ylide Stabilized with an Ester and Evaluation of
Intramolecular 1,3-Dipolar Cycloaddition. To better
control the relative stereochemistry on cycloheptane 69, we
envisaged the preparation of the substituted seven-membered
ring using a ring-closing metathesis on diene 71 (Scheme 13).
The latter would be obtained from a Claisen rearrangement of
allyl enol ether 72. Relative stereochemistry would be secured
by a diastereocontrolled alkylation of the five-membered
Scheme 10. Synthesis of Cyclization Precursor 59 with a
Nitrile
Scheme 11. Attempted Key Sequential Cyclizations with Silyl
Enol Ether-Nitrile 59
Scheme 12. Synthesis and Key Sequential Cyclizations with
Model Substrate 65
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lactone 73.30 This new approach also ensures a certain variation
of the dipolarophile since it is installed last in the sequence (70
to 69).
This new synthesis started with a sequence we already
published.31 Formamide was alkylated with bromide 75, but a
large amount of the elimination product 77 was observed
(Scheme 14). To avoid this problem, a less basic nucleophile
was necessary. Alkylation of sodium formimide, followed by
hydrolysis, produced the desired amide 76 in good yield (78%)
with no elimination side product.32 Due to a complicated
alkylation of formamide 64 with bromoacetonitrile (Scheme
12) in the model study, we chose to install an ester instead of a
nitrile as an electron-withdrawing group. Alkylation of
formamide 76 with ethyl bromoacetate generated compound
78, which was then heated to induce the Claisen rearrange-
ment33 that quantitatively furnished diene 79 (Scheme 14).
The latter was subjected to ring-closing metathesis with the
second-generation Grubbs’ catalyst,34 and the resulting
aldehyde 80 was silylated. Finally, benzyl ether deprotection,
Swern oxidation of alcohol 82, and olefination of the resulting
aldehyde using Still−Gennari conditions35 gave the key-step
precursor 83.
Unfortunately, upon activation of formamide 83 with triflic
anhydride in the presence of DTBMP, no Vilsmeier−Haack
cyclization product 85 was observed (Scheme 15). 1H NMR
analysis showed a fast protonation of the base (DTBMP) and
signals corresponding to an oxazolium ion 86 that could be
generated after the formation of triflyliminium ion 84.
Oxazolium ion 86 was not electrophilic enough to be trapped
Scheme 13. Retrosynthetic Analysis for the Core of
Daphnilactone B-Type and Yuzurimine-Type Daphniphyllum
Alkaloids
Scheme 14. Synthesis of the Cyclization Precursor 83
Scheme 15. Attempted Key Sequential Cyclizations with Silyl
Enol Ether 83
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with the internal silyl enol ether despite heating to reflux.36
Hence, we decided to reinvestigate the installation of a nitrile as
an electron-withdrawing group to avoid this problem.
Fourth Model Study: Preparation of an Azomethine
Ylide Stabilized with a Nitrile and Intramolecular 1,3-
Dipolar Cycloaddition. Installation of the cyanomethyl onto
the formamide is always low yielding, presumably because of
proton exchange between formamide anion, bromoacetonitrile,
and/or the alkylated N-(cyanomethyl)formamide. Alkylation of
the primary amine prior to formylation seemed to be more
promising. Moreover, because we had in the past some enol
ether hydrolysis issues, we designed two similar routes to
prepare either the silyl enol ether or the dipolarophile in the
last steps (approaches A and B, respectively, Scheme 16). Both
approaches start with bromide displacement with ammonia,37
followed by alkylation with bromoacetonitrile, then formyla-
tion. This sequence is performed on benzyl ether 75 in
approach A, or on free alcohol 93 in approach B without
affecting the hydroxyl group.
In the approach A, a Claisen rearrangement on compound
87, followed by a ring-closing metathesis, allowed us to
incorporate the silyl enol ether group on aldehyde 89 prior to
the dipolarophile. Deprotection of benzyl ether 90 was not as
easy as in the sequence presented in Scheme 15 (cf. 75 to
77).38 The nitrile group on 90 interfered with the hydro-
genolysis of the benzyl group (Scheme 16). We found that
conditions using Guindon’s reagent worked best to smoothly
cleave the benzyl group while preserving the nitrile, the
formamide, and even the very sensitive silyl enol ether.39
Interestingly, these conditions allowed keeping the endocyclic
alkene in place, which could later be used to incorporate the
cyclopentene ring present in the natural products. Finally,
oxidation of alcohol 91 and olefination installed the
dipolarophile in moderate yields (47% over two steps).
In the approach B, alcohol 94 was oxidized and olefinated in
a much better yield (76%, two steps). A Claisen rearrangement
and ring-closing metathesis furnished aldehyde 96.40 The
sequence ended with a silylation to generate the cyclization
precursor 92, albeit in moderate yield (40%). These two
approaches count 9−10 steps from intermediate 75 and gave
similar overall yields (8−10%).
We were finally pleased to find out that activation of
formamide 92 with triflic anhydride allowed a clean Vilsmeier−
Haack cyclization at room temperature in less than 5 min
(Scheme 17). Iminium ion 97 was then deprotonated with i-
Pr2NEt at different temperatures (40 °C in DCE, 110 °C in
Scheme 16. Synthesis of the Cyclization Precursor 92 with Two Different Approaches
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toluene, or 120 °C in chlorobenzene) to form the azomethine
ylide that engaged in the intramolecular 1,3-dipolar cyclo-
addition. While higher temperatures seemed to cause
degradation of the ylide, the cycloaddition smoothly occurred
at room temperature to form the highly congested tetracyclic
product 98 in an impressive 86% yield.
Fifth Model Study: Intramolecular 1,3-Dipolar Cyclo-
addition between Nitrile-Stabilized Azomethine Ylide
and Methyl-Substituted Alkene. A structural analysis of
daphnilactone B-type and yuzurimine-type Daphniphyllum
alkaloids shows a methyl on the pyrrolidine ring (1, R′ =
Me, Figure 1) instead of an ester group (98, Scheme 17). A
more direct access to the core of these alkaloids would involve a
methyl-substituted dipolarophile (cf. 92, CO2Me = Me) even
though we were aware that this dipolarophile could present a
reactivity issue. As shown in Scheme 18, Swern oxidation of
alcohol 94, followed by Wittig olefination, gave the desired
dipolarophile 99 with a cis geometry.41 The same three steps
used previously in approach B (Scheme 16) furnished the key-
step compound 100 (Scheme 18). It is worth mentioning that
the second-generation Grubbs’ catalyst for the ring-closing
metathesis on substrate 100 induced a problematic isomer-
ization of the cis-dipolarophile, while the first-generation
Grubbs’ catalyst preserved the integrity of the cis-alkene.42
Unfortunately, after activation of formamide 102 and
Vilsmeier−Haack cyclization, no cycloaddition product 104
was observed, even when the temperature was increased to 160
°C (Scheme 19). It thus seems that the dipolarophile really
needs to be activated for the cycloaddition to occur.
Further Derivatization of the Key Tetracyclic Product.
Functionalization of cycloadduct 98 was then undertaken.
Homologation of the aldehyde, reduction of the methyl ester,
and cleavage of the nitrile were required to advance toward
caldaphnidine C (Figure 2).43
A Horner−Wadsworth−Emmons olefination was realized on
aldehyde 98 to install the required number of carbons on this
chain (Scheme 20).44 Only the trans-isomer of the ester 105
Scheme 17. Key Sequential Cyclizations with Silyl Enol
Ether 92
Scheme 18. Synthesis of the Cyclization Precursor 102
Scheme 19. Attempted Key Sequential Cyclizations with Silyl
Enol Ether 102
Figure 2. Planned functionalization of cycloadduct 98.
Scheme 20. Derivatization of the Key Tetracyclic Product 98
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was formed, but as a mixture of three diastereomers.
Epimerization α to the methyl ester (1:1) for one of the two
diastereomers of 105 in the course of the olefination explains
this result. Any attempt to reductively remove the nitrile group
failed (Na in NH3,
45 NaBH4
46 or NaBH3CN in MeOH or
MeCN, with or without Bronsted − AcOH47 − or Lewis −
ZnBr2,
48 AgBF4
49 − acids). We thus decided to rather eliminate
the nitrile group using NaH, and vinylogous carbamate 106 was
obtained as a single diastereomer.50 Finally, all three alkenes on
106 were hydrogenated51 and the methyl ester was reduced
with LiBH4. Compound 107 was isolated without reduction of
tert-butyl ester, and the relative stereochemistry at C10 was
explained by hydrogenation from the convex face of this
crowded cage compound.52
■ CONCLUSION
This work establishes clearly the efficiency of one-pot
sequential cyclizations to build rapidly complex architectures
corresponding to the cores of natural products. The sequence
of intramolecular Vilsmeier−Haack reaction and azomethine
ylide 1,3-dipolar cycloaddition allowed the assembly of three
new cycles in a constrained bridged system, as well as the
perfect control of four of the five new stereogenic centers. The
Vilsmeier−Haack cyclization successfully generated the con-
gested quaternary center when using a reactive enol ether
nucleophile. Chemoselectivity proved to be very high when a
non-nucleophilic base was used to generate the stabilized
azomethine ylide; otherwise, nucleophiles (such as halides used
to promote desilylation to unstabilized azomethine ylides)
provoked an unwanted opening of the bridged bicyclic iminium
intermediate. Further functional group manipulations brought
the cycloadduct to what could be seen as the closest to the
natural products in the daphnilactone B-type and yuzurimine-
type Daphniphyllum family so far reported. Future work will
address the design of a nonracemic route and the installation of
the required additional quaternary center (see 1, C14) at the
ring junction of the six- and seven-membered rings, as well as
the installation of the cyclopentene ring on the cycloadduct.
■ EXPERIMENTAL SECTION
General Information. All reactions requiring anhydrous con-
ditions were conducted in flame-dried glassware under a dry nitrogen
or argon atmosphere. THF and Et2O were distilled from Na and
benzophenone under nitrogen immediately prior to use. MeCN,
benzene, DCM, DCE, i-Pr2NH, i-Pr2NEt, and toluene were distilled
from CaH2 under nitrogen immediately prior to use. MeOH was
distilled over 4 Å molecular sieves. Tf2O and CDCl3 were distilled over
a small amount of phosphorus pentoxide (P2O5) under nitrogen
immediately prior to use. Ethyl chloroformate and TBDMSOTf were
distilled under nitrogen immediately prior to use. All other required
fine chemicals were used directly without purification. Thin layer
chromatography (TLC) was conducted with precoated 60 Å 250 μm
silica gel plates with F-254 indicator and visualized using a
combination of UV and anisaldehyde, ceric ammonium molybdate,
iodine on silica, or potassium permanganate staining. Flash column
chromatography was performed using silica gel (230−400 mesh).
Melting points are uncorrected. IR spectra were recorded with a FTIR
instrument by applying substrates as thin films onto a KBr plate. 1H
and 13C NMR spectra were recorded on 300 MHz and/or 400 MHz
spectrometers. All chemical shifts are referenced to residual non-
deuterated solvent. Data for proton spectra are reported as follows:
chemical shift (multiplicity [singlet (s), doublet (d), triplet (t), quartet
(q), quintet (quint), and multiplet (m)], coupling constants [Hz],
integration). Carbon spectra were recorded with complete proton
decoupling, and the chemical shifts are reported in ppm.
Usual Reaction Workup and Purification. After addition of the
indicated aqueous solution, layers were separated. The aqueous phase
was extracted with the indicated solvent, and the combined organic
phases were washed with the indicated aqueous solution (if needed),
dried over anhydrous MgSO4, filtered, and concentrated under
reduced pressure using a rotary evaporator. The crude material was
purified by flash chromatography using silica gel with the indicated
eluent.
Allyl 2-Oxocycloheptane-1-carboxylate (23). Na0 (small cube)
was added to a solution of 22 (47 g, 0.28 mol) in allyl alcohol (300
mL) at rt. The mixture was heated to 100 °C (with a condenser) over
5 days and was allowed to cool to rt; then water was added. The usual
workup (EtOAc) and purification (5% EtOAc in hexanes) afforded a
mixture of 23 and its enolic form (50 g, 91%) as a colorless oil: 1H
NMR (300 MHz, CDCl3) δ (ppm) 12.66 (s) and 3.58 (dd, J = 10.5,
4.0 Hz) (1H), 6.03−5.84 (m, 1H), 5.32 (d, J = 17.0 Hz, 1H), 5.25 (dd,
J = 10.5, 1.0 Hz, 1H), 4.66−4.61 (m, 2H), 2.63−2.58 (m, 1H), 2.46−
2.40 (m, 2H), 2.15−2.07 (m) and 1.99−1.81 (m) (2H), 1.77−1.70
(m) and 1.67−1.56 (m) (2H), 1.54−1.41 (m, 2H); 13C NMR (75.5
MHz, CDCl3) δ 208.7, 179.9, 172.5, 170.1, 132.3, 131.7 118.3, 117.6,
101.3, 65.5, 64.8, 58.8, 43.0, 35.3, 31.9, 29.5, 27.9, 27.5, 27.3, 24.5,
24.3; IR (film) ν (cm−1) 2929, 2854, 1744, 1705, 1637, 1610, 1239,
1213; MS m/z (rel %) 196 (7) [M+], 139 (26), 81 (100), 55 (99), 41
(90); HRMS (IE) calcd for C11H16O3 196.1099, found 196.1104.
Allyl 1-(But-3-enyl)-2-oxocycloheptane-1-carboxylate (24).
NaH (60% in mineral oil, 251 mg, 6.30 mmol) was added to a solution
of 23 (1.03 g, 0.52 mmol) in DMF (14 mL) at rt. The mixture was
stirred 10 min at rt; then bromobut-3-ene (582 μL, 5.72 mmol) was
added. The resulting mixture was stirred to 40 °C for 24 h and then
was allowed to cool to rt. DMF was removed on a rotary evaporated
using a mechanical pump; then water was added. The usual workup
(Et2O) and purification (2% EtOAc in hexanes) afforded 24 (1.1 g,
85%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 5.94−
5.71 (m, 2H), 5.32 (d, J = 17.0 Hz, 1H), 5.24 (d, J = 10.5, 1H), 5.01
(d, J = 18.5 Hz, 1H), 4.95 (d, J = 10.5 Hz, 1H), 4.62 (d, J = 5.0 Hz,
2H), 2.67−2.59 (m, 1H), 2.52−2.45 (m, 1H), 2.21−1.96 (m, 4H),
1.81−1.47 (m, 8H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 208.9,
171.9, 137.8, 131.5, 118.5, 114.7, 65.4, 62.4, 41.9, 34.5, 32.7, 29.8, 28.8,
25.5, 24.7; IR (film) ν (cm−1) 3078, 2932, 2860, 1737, 1710, 1453,
1201, 1148, 993, 939; MS m/z (rel %) 250 (1) [M+], 209 (18), 196
(100), 138 (67), 84 (47); HRMS (IE) calcd for C15H22O3 250.1569,
found 250.1576.
2-(But-3-enyl)cyclohept-2-enone (25) and 2-(But-3-enyli-
dene)cycloheptanone (26). A solution of Pd2(dba)3 (40 mg, 0.07
mmol, weighed in a glovebox) in MeCN (3 mL) was heated to reflux;
then a solution of 24 (3.5 g, 14 mmol) in MeCN (3 mL) was added
dropwise. After 2 h at reflux, the mixture was allowed to cool to rt and
was filtered on Florisil. The solution was concentrated under reduced
pressure, and the usual purification (2% Et2O in hexanes) afforded 25
(0.98 g, 43%) and 26 (0.98 g, 43%) as colorless oils. 25: 1H NMR
(300 MHz, CDCl3) δ (ppm) 6.46 (t, J = 6.5 Hz, 1H), 5.74 (ddt, J =
16.5, 10.0, 6.5 Hz, 1H), 4.96 (dd, J = 15.5, 1.5 Hz, 1H), 4.92 (d, J = 8.0
Hz, 1H), 2.55 (t, J = 6.5 Hz, 2H), 2.38−2.29 (m, 4H), 2.12 (q, J = 7.0
Hz, 2H), 1.77−1.67 (m, 4H); 13C NMR (75.5 MHz, CDCl3) δ (ppm)
205.0, 142.9, 141.8, 138.1, 114.8, 42.5, 33.3, 32.4, 27.3, 25.0, 21.4; IR
(film) ν (cm−1) 3580−3077, 1656, 1637; MS m/z (rel %) 164 (25)
[M+], 149 (30), 135 (32), 121 (27), 107 (39), 95 (100), 79 (57), 67
(93); HRMS (IE) calcd for C11H16O1 164.1201, found 164.1204. 26:
1H NMR (300 MHz, CDCl3) δ (ppm) δ 6.58 (t, J = 7.0 Hz, 1H), 5.81
(ddt, J = 16.5, 10.0, 6.0 Hz, 1H), 5.09−5.02 (m, 2H), 2.91 (t, J = 6.0
Hz, 2H), 2.62−2.59 (m, 2H), 2.45−2.41 (m, 2H), 1.78−1.61 (m, 6H).
t-Butyl syn-(2-(But-3-enyl)-3-oxocycloheptyl)acetate (28)
and t-Butyl anti-(2-(But-3-enyl)-3-oxocycloheptyl)acetate
(29). A solution of n-BuLi (50.0 mL, 2.45 M in hexanes, 123
mmol) was added dropwise to a solution of i-Pr2NH (20.3 mL, 143
mmol) in THF (26 mL) at 0 °C. The mixture was stirred for 15 min at
0 °C and then was cooled to −78 °C, and t-BuOAc (15.0 mL, 111
mmol) was added. The mixture was stirred for 3 h at −78 °C, then
warmed up to −35 °C (critical), and TMSCl (16.9 mL, 134 mmol)
was added. The mixture was stirred for 3 h; then a distillation
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apparatus was installed directly on the reaction flask. Distillation under
reduced pressure (∼10−15 mmHg, fraction collected at 65−74 °C)
furnished a 1.0:2.0 mixture of C-silylated product and O-silylated
product 27 (15.9 g, 57%) as a colorless oil. The mixture (7.2 g, 63%
pure, 24 mmol) was added to a solution of 25 (2.8 g, 17 mmol) in
THF (300 mL). The mixture was cooled to −78 °C, and TiCl4 (285
μL, 2.60 mmol) was added dropwise. The mixture was strirred for 3 h
at −78 °C; then acetic acid (3.0 mL, 52 mmol) was added. The
resulting mixture was stirred for 20 min; then water was added. The
usual workup (DCM) and purification (DCM) afforded a hardly
separable 4:1 mixture of 28 and 29 (3.59 g, 75%) as a colorless oil. A
small fraction of pure compounds was obtained and characterized. 28:
1H NMR (300 MHz, CDCl3) δ (ppm) 5.75 (ddt, J = 17.0, 10.0, 6.5
Hz, 1H), 5.00 (d, J = 17.0 Hz, 1H), 4.96 (d, J = 7.0 Hz, 1H), 2.90−
2.85 (m, 1H), 2.51 (t, J = 5.0 Hz) and 2.46 (t, J = 5.0 Hz) (1H), 2.39−
2.27 (m, 2H), 2.20 (dd, J = 15.5, 3.5 Hz, 1H), 2.06−1.63 (m, 9H),
1.48−1.25 (m, 2H), 1.42 (s, 9H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 213.6 (s), 171.9 (s), 138.0 (d), 114.8 (t), 80.0 (s), 53.0 (d),
44.1 (t), 36.0 (d), 34.8 (t), 33.8 (t), 31.8 (t), 27.8 (q), 23.8 (t), 23.2
(t); IR (film) ν (cm−1) 2976, 2930, 1728, 1699, 1146; MS m/z (rel %)
280 (1) [M+], 224 (32) [M+ − C4H8], 170 (100), 152 (44), 111 (98);
HRMS calcd for C17H28O3: 280.2038, found: 280.2044. 29:
1H NMR
(300 MHz, CDCl3) δ (ppm) 5.75 (ddt, J = 17.0, 10.0, 6.5 Hz, 1H),
5.00 (d, J = 17.0 Hz, 1H), 4.96 (d, J = 7.0 Hz, 1H), 2.61 (dt, J = 11.5,
3.5 Hz, 1H), 2.40 (dd, J = 15.5, 3.5 Hz, 1H), 2.34−2.26 (m, 1H), 2.21
(dt, J = 10.0, 4.0 Hz, 1H), 2.13−2.05 (m, 1H), 2.03−1.76 (m, 4H),
1.74−1.52 (m, 4H), 1.49−1.42 (m, 2H), 1.45 (s, 9H), 1.27−1.78 (m,
1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 215.1 (s), 171.9 (s),
137.7 (d), 115.2 (t), 80.6 (s), 57.4 (d), 41.0 (t), 40.4 (t), 37.7 (d), 32.9
(t), 31.5 (t), 30.2 (d), 28.1 (q), 27.8 (t), 26.0 (t); IR (film) ν (cm−1)
2978, 2931, 2854, 1728, 1703, 1367, 1250, 1151; MS m/z (rel %) 280
(2) [M+], 223 (31) [M+ − C4H9], 170 (100), 152 (38), 111 (50);
HRMS calcd for C17H28O3: 280.2038, found: 280.2044.
t-Butyl 2-(2-(But-3-enyl)-3-(2-(dimethylphenylsilyl)ethyli-
dene)cycloheptyl)acetate (30). PhMe2SiCl (8.2 mL, 49 mmol)
was added to a suspension of Li0 (2.0 g, 290 mmol) in THF (49 mL)
at 0 °C. The mixture was stirred for 18 h at 0 °C; then 39 mL of this
solution was transferred to a flask containing a suspension of CuCN
(1.9 g, 21 mmol, weighed in a glovebox) in THF (40 mL) at 0 °C. The
mixture was stirred for 4.5 h at 0 °C. Meanwhile, in a separate flask,
vinylmagnesium bromide (11 mL, 1 M in THF, 11 mmol) was added
dropwise to a solution of 28 and 29 (2.0 g, 4:1 syn: anti, 7.1 mmol) in
THF (120 mL) at rt. The mixture was stirred for 2.25 h at rt; then
ClCO2Et (1.4 mL, 18 mmol) was added. After 15 min of stirring at 0
°C, the solution was transferred via canula to the solution of
silylcuprate. The resulting mixture was allowed to warm to rt over 3 h;
then a saturated aqueous NH4Cl solution was added. The usual
workup (EtOAc) and purification (5% Et2O in hexanes) afforded an
inseparable mixture of E/Z isomers (4.0:1.0) of 30 (2.1 g, 68%; 85%
based on 28 only) as a colorless oil:53 1H NMR (300 MHz, CDCl3) δ
(ppm) 7.53−7.50 (m, 2H), 7.36−7.33 (m, 3H), 5.84−5.71 (m, 1H),
5.16 (t, J = 8.5 Hz, 1H), 4.98−4.90 (m, 2H), 2.25−1.78 (m, 8H),
1.74−1.60 (m, 2H), 1.58−1.17 (m, 8H), 1.43 (s, 9H), 0.29 (s) and
0.28 (s) (6H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 173.0, 139.2,
138.3, 133.6, 129.0, 127.7, 123.4, 121.6, 114.3, 79.8, 50.0, 41.5, 41.1,
40.9, 39.8, 39.8, 34.2, 32.7, 32.6, 32.3, 32.0, 28.2, 27.7, 27.2, 26.4, 25.8,
25.0, 17.7, 17.2, −3.0; IR (film) ν (cm−1) 3069, 2926, 2864, 1723,
1144, 909, 734; MS m/z (rel %) 426 (5) [M+], 353 (7), 176 (14), 135
(100); HRMS calcd for C27H42O2Si: 426.2954, found: 426.2950.
2-(2-(But-3-enyl)-3-(2-(dimethylphenylsilyl)ethylidene)-
cycloheptyl)acetic Acid (31). KOH (340 mg, 71.3 mmol) was
added to a solution of 30 (2.08 g, 4.88 mmol) in a mixture of EtOH
(240 mL) and water (5 mL). The resulting mixture was heated to
reflux for 5 days and then allowed to cool to rt. Part of the EtOH was
removed under reduced pressure on the rotary evaporator. pH was
adjusted to 1 at 0 °C with 1 N H2SO4. The usual workup (EtOAc) and
purification (5 to 50% EtOAc in hexanes) afforded an inseparable
mixture of E/Z isomers (4.0:1.0) of 31 (1.3 g, 72%) as a colorless oil:
1H NMR (300 MHz, CDCl3) δ (ppm) 7.55−7.52 (m, 2H), 7.37−7.35
(m, 3H), 5.79 (ddt, J = 17.0, 10.5, 6.5 Hz, 1H), 5.19 (t, J = 8.5 Hz,
1H), 4.97 (d, J = 17.0 Hz, 1H), 4.94 (d, J = 10.0 Hz, 1H), 2.44−2.25
(m), 2.19−2.11 (m), 2.07−1.82 (m), and 1.79−1.21 (m) (17H), 0.57
(s) and 0.49−0.37 (m) (1H), 0.31 (s, 6H); 13C NMR (75.5 MHz,
CDCl3) δ (ppm) 180.5 (s), 139.0 (d), 137.8 (s), 133.6 (d), 129.0 (d),
127.8 (d), 123.6 (d), 121.8 (d), 114.5 (d), 49.8 (d), 41.6 (d), 40.3 (d),
38.1 (t), 34.3 (t), 32.5 (t), 32.2 (t), 32.0 (t), 28.6 (t), 28.1 (t), 27.1 (t),
26.3 (t), 25.4 (t), 24.9 (t), 17.7 (t), 17.2 (t), −3.0 (q); IR (film) ν
(cm−1) 3358−2511 (br), 2924, 1705, 1425, 1248, 833; MS m/z (rel
%) 370 (4) [M+], 251 (8), 176 (10), 135 (100); HRMS calcd for
C23H34O2Si: 370.2328, found: 370.2321.
N-(2-(But-3-enyl)-3-(2-(dimethylphenylsilyl)ethylidene)-
cycloheptyl)methyl-N-methyl-formamide (20). ClCO2Et (195
μL, 2.07 mmol) was added to a solution of 31 (750 mg, 2.03 mmol)
and i-Pr2NEt (439 μL, 2.52 mmol) in acetone (7.5 mL) at 0 °C, and
the mixture was stirred for 30 min at 0 °C. Then an aqueous solution
of NaN3 (5.9 M, 690 μL, 4.08 mmol) was added. The resulting
mixture was stirred for 1 h at 0 °C, and cold water was added. After the
usual workup (toluene), anhydrous toluene (2 mL) was added and the
mixture was heated to reflux for 1 h and then allowed to cool to rt.
Toluene was removed under reduced pressure. Crude isocyanate was
dissolved in THF (25 mL), and LiAlH4 (745 mg, 2.03 mmol) was
added. The mixture was heated to reflux for 16 h and then allowed to
cool to rt. Water (400 μL) was added (exotherm!). After 5 min, an
aqueous solution of NaOH (15%, 400 μL) was added. After 5 min,
another portion of water (1.16 mL) was added. The mixture was
stirred for 30 min, and MgSO4 was added. After an additional 10 min
of stirring, the mixture was filtered and concentrated under reduced
pressure. Crude N-methylamine was dissolved in THF (14 mL), and
N-formylbenzotriazole (390 mg, 2.65 mmol) was added. The mixture
was stirred at rt for 15 h, and aqueous NaOH (2 N) was added.
Stirring was continued for 10 min; then water was added. The usual
workup (DCM) and purification (30 to 50% EtOAc in hexanes)
afforded an inseparable mixture of E/Z isomers (4.0:1.0) and rotamers
of 20 (555 mg, 71%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ
(ppm) 8.06 (s), 7.98 (s), and 7.92 (s) (1H), 7.52−7.50 (m, 2H),
7.36−7.34 (m, 3H), 5.83−5.69 (m, 1H), 5.17 (t, J = 8.5 Hz) and
4.98−4.89 (m) (3H), 3.23−3.20 (m), 3.10−2.90 (m) and 2.60−2.55
(m) (2H), 2.86 (s), 2.83 (s), 2.80(s), and 2.77 (s) (3H), 2.31−1.85
(m), 1.82−1.40 (m), and 1.33−1.14 (m) (14H), 0.28 (s, 6H); 13C
NMR (75.5 MHz, CDCl3) δ (ppm) 162.9, 139.2, 138.7, 138.0, 133.6,
124.0, 127.7, 123.0, 122.2, 122.0, 114.7, 114.3, 54.2, 52.8, 48.0, 47.4,
41.3, 41.0, 39.0, 34.6, 32.3, 32.1, 29.6, 28.7, 28.1, 27.7, 27.2, 27.0, 26.8,
26.3, 26.0, 25.1, 17.7, 17.4, −3.0; IR (film) ν (cm−1) 3073, 2924, 2859,
1681, 834; MS m/z (rel %) 383 (9) [M+], 342 (63) [M+ − C3H5], 328
(13), 234 (16), 135 (100); HRMS calcd for C24H37N1O1Si: 383.2644,
found: 383.2634.
rel-(1S,2S)-N-(2-(But-3-en-1-yl)-3-(2-(dimethylphenylsilyl)-
ethylidene)cycloheptylmethyl)-(trifluoromethanesulfonyl-
methylene)methanaminium Trifluoromethanesulfonate (32).
Tf2O (10 μL, 0.061 mmol) was added to 20 (20 mg, 0.056 mmol) and
i-Pr2NEt (11 μL, 0.061 mmol) in CDCl3 (1.5 mL) at 0 °C in a NMR
tube. The 1H NMR spectrum of 32 was recorded after 15 min at rt
(see the SI).
N-Methyl-5-(dimethylphenylsilylmethyl-11-(but-3-enyl)-3-
azabicyclo[4.4.1]undec-6-ene (35). Tf2O (14 μL, 0.0831 mmol)
was added to 20 (30 mg, 0.078 mmol) and DTBMP (32 mg, 0.16
mmol) in DCE (1.5 mL) at 0 °C. The mixture was stirred for 5 min at
rt, heated to reflux for 1 h, and then allowed to cool to rt.
NaHB(OAc)3 (83 mg, 0.39 mmol) was added, the mixture was stirred
vigorously for 17 h at rt, and then saturated aqueous NaHCO3 was
added. The usual workup (EtOAc) and purification (50 to 100%
EtOAc in hexanes) afforded an inseparable mixture of diastereomers of
35 (14 mg, 50%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ
(ppm) 7.51−7.48 (m, 2H), 7.34−7.32 (m, 3H), 5.77 (ddt, J = 17.0,
10.5, 6.5 Hz, 1H), 5.63 (t, J = 7.0 Hz, 1H), 4.94 (d, J = 17.0 Hz, 1H),
4.91 (d, J = 6.5 Hz, 1H), 2.89 (t, J = 7.5 Hz, 1H), 2.77 (dd, J = 11.0,
5.5 Hz, 1H), 2.64−2.57 (m, 1H), 2.42−2.23 (m, 3H), 2.14 (s) and
2.06 (s) (3H), 2.01−1.81 (m, 2H), 1.79−1.17 (m, 8H), 0.99−0.88 (m,
2H), 0.76 (d, J = 7.0 Hz) and 0,71 (t, J = 7.0 Hz) (2H), 0.27 (s) and
0.25 (s) (6H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 146.9, 139.3,
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133.5, 128.7, 127.7, 122.7, 114.1, 73.9, 61.2, 49.5, 43.8, 34.6, 34.5, 33.6,
32.5, 26.1, 20.7, 17.1, −1.6, −2.0. IR (film) ν (cm−1) 2926, 2921; MS
m/z (rel %) 367 (28) [M+], 326 (11), 313 (47), 232 (51), 135 (100).
HRMS calcd for C24H37N1Si: 367.2695, found: 367.2703.
tert-Butyl 2-(2-(But-3-en-1-yl)-3-(methoxymethylene)cyclo-
heptyl)acetate (36). A solution of KHMDS (0.5 M in toluene,
42.8 mL, 21.4 mmol) was added to a solution of Ph3PCH2OMeCl
(7.33 g, 21.4 mmol) in THF (120 mL) at 0 °C. The mixture was
stirred for 30 min at rt. A solution of 28/29 (2.91 g, 10.4 mmol) in
THF (30 mL) was added at 0 °C, and the resulting mixture was stirred
at rt for 23 h. Saturated aqueous NaHCO3 was added, THF was
removed under reduced pressure, and water was added. The usual
workup (EtOAc) and purification (30 to 100% toluene in hexanes)
gave a hardly separable mixture of E/Z and syn/anti isomers of 36
(3.02 g, 94%) as a colorless oil. A small portion of the mixture of
diastereomers was separated for characterization. Two portions
containing two different diastereomers were characterized: Portion 1
as a 3:2 mixture of diastereomers: 1H NMR (300 MHz, CDCl3) δ
(ppm) 5.89 (s) and 5.62 (s) (1H), 5.88−5.70 (m, 1H), 5.01−4.89 (m,
2H), 3.56 (s) and 3.49 (s) (3H), 2.56−2.48 (m), 2.40 (dd, J = 15.5,
4.0 Hz), and 2.34 (dd, J = 15.0, 4.0 Hz) (2H), 2.10−1.65 (m, 7H),
1.60−1.25 (m, 7 H), 1.44 (s, 9H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 172.9, 144.6, 143.6, 139.5, 139.0, 120.6, 119.9, 114.3, 113.9,
80.0, 79.9, 59.3, 59.0, 46.8, 41.7, 41.0, 40.6, 32.7, 32.3, 32.2, 31.9, 31.6,
29.6, 28.8, 28.1, 27.7, 23.9; IR (film) ν (cm−1) 2977, 2928, 2854, 1729,
1663, 1458, 1369, 1142, 1126; MS m/z (rel %): 308 (1) [M+], 251
(26) [M+ − C4H9], 194 (90), 159 (86), 134 (100); HRMS (EI) calcd
for C15H23O3 [M
+ − C4H9]: 251.1647, found 251.1657. Portion 2 as a
8:1 mixture of diastereomers, only the major diastereomer reported:
1H NMR (300 MHz, CDCl3) δ (ppm) 5.85−5.72 (m) and 5.76 (s)
(2H), 4.98 (d, J = 17.0 Hz, 1H), 4.93 (d, J = 10.5 Hz, 1H), 3.55 (s,
3H), 2.54−2.44 (m, 1H), 2.22−1.98 (m, 6H), 1.96−1.80 (m, 1H),
1.72−1.23 (m, 8H), 1.44 (s, 9H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 173.4, 143.9, 139.4, 119.8, 114.6, 79.9, 59.1, 45.0, 42.0, 40.3,
31.9, 31.6, 27.8, 26.1, 26.0, 25.7, 24.6; IR (film) ν (cm−1) 2977, 2928,
2854, 1729, 1663, 1458, 1369, 1142, 1126; MS m/z (rel %): 251 (20)
[M+ − C4H9], 220 (22), 194 (73), 159 (71), 134 (100), 57 (95), 41
(76); HRMS (EI) calcd for C15H23O3 [M
+ − C4H9] 251.1647, found
251.1655.
2-(2-(But-3-en-1-yl)-3-(methoxymethylene)cycloheptyl)-
acetic Acid (37). KOH (2.11 g, 37.6 mmol) was added to a solution
of 36 (1.16 g, 3.76 mmol) in a mixture of EtOH (145 mL) and water
(3 mL). The resulting mixture was refluxed for 5 days. Then, a buffer
solution (pH 7.4, 20 mL) was added and EtOH was removed under
reduced pressure. Aqueous citric acid (10%) was added at 0 °C until
an acidic pH (3) was obtained. The usual workup (EtOAc, washed
with brine) afforded 37 (949 mg, 100%) as brown oil. For
characterization, a small portion was purified by flash chromatography
using silica gel (0 to 2% MeOH in DCM). An inseparable mixture of
E/Z and syn/anti isomers of 37 was obtained as a brown oil: 1H NMR
(300 MHz, CDCl3) δ (ppm) 5.91 (s), 5.89−5.73 (m), 5.78 (s), and
5.64 (s) (2H), 4.99 (d, J = 17.5 Hz, 1H), 4.94 (d, J = 10.5 Hz, 1H),
3.57 (s), 3.56 (s), and 3.50 (s) (3H), 2.79 (dt, J = 11.5, 3.5 Hz) and
2.60−2.40 (m) (1H), 2.40−1.22 (m, 15H); 13C NMR (75.5 MHz,
CDCl3) δ (ppm) 180.8, 145.0, 144.0, 139.6, 139.4, 139.1, 120.2, 119.7,
119.5, 114.7, 114.4, 114.2, 59.1, 58.8, 46.6, 45.0, 41.3, 41.0, 40.6, 40.2,
40.0, 39.7, 39.6, 38.7, 32.2, 32.0, 31.7, 31.6, 31.2, 29.1, 28.8, 28.4, 27.8,
27.3, 26.1, 25.8, 25.7, 25.2, 24.9, 24.6, 23.4; IR (film) ν (cm−1) 3081,
2927, 2856, 1706, 1452, 1408, 1217, 1125; MS m/z (rel %): 252 (4)
[M+], 220 (9), 197 (53), 134 (100), 119 (46); HRMS (EI) calcd for
C15H24O3 [M
+] 252.1725, found 252.1727.
N-((2-(But-3-en-1-yl)-3-(methoxymethylene)cycloheptyl)-
methyl)-N-methylformamide (38). Following the procedure used
to prepare 20, a solution of 37 (1.01 g, 3.98 mmol) in acetone (14.0
mL) was treated with ClCO2Et (395 μL, 4.18 mmol) and i-Pr2NEt
(0.87 mL, 5.0 mmol) for 30 min at 0 °C and then with an aqueous
solution of NaN3 (5.9 M, 1.35 mL, 7.96 mmol) for 1 h at 0 °C. Crude
acylazide was then refluxed in toluene (14.0 mL) for 1.5 h to afford the
corresponding isocyanate (993 mg) as a brown oil: 1H NMR (300
MHz, CDCl3) δ (ppm) 5.91 (s), 5.82 (s), 5.78 (s), and 5.67 (s) (1H),
5.87−5.72 (m, 1H), 5.03−4.92 (m, 2H), 3.57 (s), 3.56 (s), 3.52 (s),
and 3.50 (s) (3H), 3.41−3.09 (m) and 3.18 (dd, J = 7.5, 3.5 Hz) (2H),
2.97 (d, J = 12.0 Hz) and 2.65−2.49 (m) (1H), 2.22−1.19 (m, 13H).
A solution of crude isocyanate (993 mg, 3.98 mmol) in THF (25 mL)
was treated with LiAlH4 (755 mg, 19.9 mmol) at reflux for 20 h and
then with water (750 μL), aqueous NaOH (15%, 750 μL), and water
(2.25 mL) to afford N-methylamine (845 mg, 89%) as pale yellow oil:
1H NMR (300 MHz, CDCl3) δ (ppm) 5.91−5.70 (m), 5.80 (s), and
5.63 (s) (2H), 4.99 (d, J = 19.0 Hz, 1H), 4.94 (d, J = 10.5 Hz, 1H),
3.56 (s), 3.54 (s), 3.50 (s), and 3.49 (s) (3H), 2.62−2.46 (m), 2.44−
2.31 (m), 2.42 (s), and 2.41 (s) (4H), 2.21−1.78 (4H), 1.72−1.18 (m,
11H), 0.98−0.75 (m, 1H); IR (film) ν (cm−1) 3358, 3325, 3073, 2925,
2852, 2788, 1661, 1639, 1461, 1444, 1247, 1220, 1125, 907. A solution
of crude N-methylamine (845 mg, 3.56 mmol) in THF (24 mL) was
treated with N-formylbenzotriazole (680 mg, 4.63 mmol) for 18 h at rt
and then with aqueous NaOH (2 N). The usual workup (DCM) and
purification (10 to 40% EtOAc in hexanes) afforded an inseparable
mixture of diastereomers and rotamers of 38 (820 mg, 78% over 4
steps) as a pale yellow oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 8.09
(s), 8.07 (s), 8.01 (s), 7.99 (s), and 7.98 (s) (1H), 5.92−5.64 (m) and
5.77 (s) (2H), 5.06−4.89 (m, 2H), 3.57 (s), 3.56 (s), 3.55 (s), 3.54
(s), and 3.50 (s) (3H), 3.30 (dd, J = 13.5, 7.5 Hz), 3.20 (dd, J = 13.5,
8.0 Hz), 3.14 (dd, J = 14.0, 8.0 Hz), and 3.02 (dd, J = 14.0, 7.5 Hz)
(2H), 2.92 (s), 2.92 (s), 2.90 (s), 2.87 (s), and 2.83 (s) (3H), 2.62−
2.47 (m) and 2.24−1.07 (m) (14H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 163.7, 163.5, 163.2, 145.2, 144.2, 143.8, 143.5, 139.4, 139.3,
139.0, 138.8, 119.9, 119.4, 119.3, 119.0, 115.0, 114.6, 114.5, 114.2,
59.1, 58.9, 54.2, 53.3, 53.0, 48.4, 47.5, 47.1, 45.7, 44.9, 44.5, 43.9, 43.4,
42.9, 42.1, 41.8, 41.0, 40.2, 40.0, 37.9, 36.0, 34.4, 33.8, 32.7, 32.4, 32.2,
31.9, 31.7, 31.5, 31.3, 31.1, 29.6, 29.3, 29.2, 29.1, 28.7, 28.3, 28.2, 27.5,
27.2, 26.9, 26.8, 26.5, 26.3, 25.6, 25.4, 25.1, 24.9, 24.6, 24.5, 24.4, 24.2,
24.0, 23.5; IR (film) ν (cm−1) 3073, 2924, 2850, 1666, 1453, 1395,
1222, 1123; MS m/z (rel %): 264 (1) [M+], 250 (4), 206 (9), 174
(15), 151 (100); HRMS (EI) calcd for C16H26NO2 [M
+ − H]
264.1963, found 264.1967.
N-((2-(But-3-en-1-yl)-3-formylcycloheptyl)methyl)-N-
methylformamide (39). An aqueous HCl solution (2 N, 5.20 mL,
10.4 mmol) was added to a solution of 38 (527 mg, 1.99 mmol) in
THF (10 mL). The reaction mixture was heated at 55 °C for 3 h; then
saturated aqueous NaHCO3 was added. The usual workup (Et2O) and
purification (40 to 70% EtOAc in hexanes) afforded a mixture of
diastereomers and rotamers of 39 (410 mg, 82%) as a pale yellow oil.
Only the major fraction containing two diastereomers was
characterized: 1H NMR (300 MHz, CDCl3) δ (ppm) 9.63 (s) and
9.62 (s) (1H), 8.09 (s) and 8.00 (s) (1H), 5.87−5.70 (m, 1H), 5.09−
4.90 (m, 2H), 3.47 (dd, J = 13.5, 8.5 Hz) and 3.22−3.00 (m) (2H),
2.92 (s) and 2.85 (s) (3H), 2.54−2.46 (m, 1H), 2.24−1.27 (m, 14H);
13C NMR (75.5 MHz, CDCl3) δ (ppm) 205.6, 204.9, 163.5, 163.4,
138.7, 138.0, 115.8, 115.1, 53.7, 53.3, 47.4, 35.6, 35.3, 35.0, 34.3, 31.8,
31.6, 29.4, 27.1, 27.0, 26.8, 26.4, 25.9, 25.6, 25.4, 24.4; IR (film) ν
(cm−1) 2928, 2861, 1721, 1674, 1452, 1395, 1076; MS m/z (rel %):
252 (14) [MH+], 251 (8) [M+], 222 (30) [M+ − CHO], 192 (58),
172 (55), 95 (82), 81 (100); HRMS (EI) calcd for C15H25NO2 [M
+]
251.1885, found 251.1896.
N-((2-(But-3-en-1-yl)-3-(((tert-butyldimethylsilyl)oxy)methyl-
ene)cycloheptyl )methyl ) -N -methylformamide (40) .
TBDMSOTf (201 μL, 0.877 mmol) was added to a solution of 39
(147 mg, 0.585 mmol) and i-Pr2NEt (153 μL, 0.877 mmol) in DCM
(10 mL) at 0 °C. The solution was stirred for 18 h at rt; then saturated
aqueous Na2CO3 and saturated aqueous NaCl were added. The usual
workup (DCM) and purification using silica gel saturated with Et3N
(25% EtOAc in hexanes) afforded a mixture of diastereomers and
rotamers of 40 (160 mg, 75%) as a pale yellow oil, separable in two
different portions for characterization: Portion 1: 1H NMR (300 MHz,
CDCl3) δ (ppm) 8.09 (s), 8.05 (s), 8.00 (s), and 7.98 (s) (1H), 6.20
(s), 6.07 (s), and 6.04 (s) (1H), 5.88−5.72 (m, 1H), 5.05−4.84 (m,
2H), 3.42 (dd, J = 13.5, 8.5 Hz), 3.18 (dd, J = 14.0, 7.0 Hz), 3.14 (dd, J
= 13.5, 7.0 Hz), and 3.06 (dd, J = 14.0, 8.0 Hz) (2H), 2.91 (s) and
2.85 (s) (3H), 2.24−2.10 (m) and 2.08−1.04 (m) (14H), 0.91 (s,
9H), 0.11 (s, 6H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 163.7,
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163.2, 139.7, 139.2, 135.9, 135.5, 122.7, 121.6, 114.7, 114.3, 54.6, 53.8,
47.6, 41.3, 40.1, 39.9, 38.0, 36.5, 36.0, 34.3, 33.1, 32.3, 32.1, 31.7, 31.4,
29.4, 29.3, 28.7, 28.4, 27.8, 27.4, 27.1, 26.9, 25.3, 24.9, 24.7, 24.3, 17.8,
−5.8, −5.9; IR (film) ν (cm−1) 2953, 2928, 2857, 1682, 1462, 1387,
1254, 1164; MS (EI) m/z (rel %): 365 [M+] (1), 350 [M+ − CH3]
(3), 308 [M+ − C4H9] (100), 251 (66); HRMS (EI) calcd for
C21H38NO2Si [M
+ − H] 364.2672, found 364.2680. Portion 2: 1H
NMR (300 MHz, CDCl3) δ (ppm) 8.09 (s), 8.07 (s), 7.99 (s), and
7.97 (s) (1H), 6.07 (s) and 5.92 (s) (1H), 5.84−5.69 (m, 1H), 5.04−
4.90 (m, 2H), 3.32 (dd, J = 13.5, 7.5 Hz), 3.22−3.08 (m), 3.15 (dd, J =
14.0, 8.0 Hz), and 3.01 (dd, J = 14.0, 7.5 Hz) (2H), 2.91 (s), 2.88 (s),
2.84 (s), and 2.82 (s) (3H), 2.70−2.55 (m), 2.13−1.90 (m), and
1.87−1.17 (m) (14H), 0.91 (s, 9H), 0.11 (s, 6H); 13C NMR (75.5
MHz, CDCl3) δ (ppm) 163.6, 163.3, 139.5, 139.0, 136.2, 135.8, 123.7,
123.1, 115.0, 114.5, 54.3, 53.3, 47.6, 44.4, 42.9, 42.1, 41.9, 34.3, 32.6,
32.4, 31.9, 31.7, 31.5, 29.9, 29.4, 29.3, 29.2, 28.3, 27.9, 26.7, 26.5, 25.7,
25.5, 25.3, 24.7, 24.6, 23.5, 17.9, −5.9; IR (film) ν (cm−1) 3074, 2927,
2856, 1681, 1392, 1253, 1163; MS (EI) m/z (rel %): 365 [M+] (1), 35
[M+ − CH3] (2), 308 [M+ − C4H9] (100), 251 (56); HRMS (EI)
calcd for C21H38NO2Si [M
+ − H] 364.2672, found 364.2666.
rel-(1S,6S)-10-(But-3-en-1-yl)-8-methyl-8-azabicyclo[4.3.1]-
decane-1-carbaldehyde (43). Tf2O (41 μL, 0.24 mmol) was added
to a solution of 40 (81 mg, 0.22 mmol) and DTBMP (50 mg, 0.24
mmol) in DCE (3.0 mL) at rt. After 15 min, the solution was heated at
80 °C for 3 h. Progression of the reaction was monitored by 1H NMR.
The mixture was concentrated under reduced pressure, and the
product was solubilized in MeOH (3.0 mL). NaBH4 (42 mg, 1.1
mmol) was added at 0 °C, and the mixture was stirred at rt for 6 h.
Aqueous NaOH (1 N) was added, and solvent was removed under
reduced pressure. Water was added. The usual workup (DCM) and
purification (0 to 5% EtOAc in hexanes) afforded a hardly separable
mixture of diastereomers of 43 (25 mg, 48%) as a yellow oil. A small
portion of the major diastereomer was isolated and characterized: 1H
NMR (300 MHz, CDCl3) δ (ppm) 9.32 (s, 1H), 5.74 (ddt, J = 17.0,
10.0, 7.0 Hz, 1H), 5.00 (d, J = 17.0 Hz) and 4.97 (d, J = 10.0 Hz)
(2H), 2.41 (d, J = 12.5 Hz) and 2.38 (d, J = 12.5 Hz) (2H), 2.24−2.10
(m) and 2.21 (s) (6H), 2.02−1.85 (m, 5H), 1.80−1.70 (m, 2H),
1.67−1.46 (m, 5H), 1.15−1.07 (m, 1H); 13C NMR (75.5 MHz,
CDCl3) δ (ppm) 203.2, 138.0, 115.2, 57.6, 57.5, 52.0, 47.1, 36.3, 35.7,
35.5, 34.5, 32.8, 29.3, 26.7, 26.6; IR (film) ν (cm−1) 2933, 2846, 2792,
2692, 1723, 1465, 1446; MS (EI) m/z (rel %): 235 [M+] (32), 206
(100); HRMS (EI) calcd for C15H25NO [M
+] 235.1936, found
235.1935.
(9H-Fluoren-9-yl)methyl N-((2-(But-3-en-1-yl)-3-(methoxy-
methylene)cycloheptyl)methyl)carbamate (44). Following the
procedure used to prepare 20, a solution of 37 (819 mg, 3.24 mmol)
in acetone (11 mL) was treated with ClCO2Et (321 μL, 3.41 mmol)
and i-Pr2NEt (0.70 mL, 4.1 mmol) for 30 min at 0 °C and then with
an aqueous solution of NaN3 (5.9 M, 1.10 mL, 6.50 mmol) for 1 h at 0
°C. Crude acylazide was then refluxed in toluene (11.0 mL) for 1.5 h
to afford the corresponding isocyanate. The latter was dissolved in
benzene (24 mL); then 9-fluorenemethanol (954 mg, 4.86 mmol) and
Ti(Ot-Bu)4 (248 μL, 0.648 mmol) were added at 0 °C. The mixture
was refluxed for 3 h; then saturated aqueous NH4Cl was added. The
usual workup (Et2O) and purification (5 to 25% EtOAc in hexanes)
afforded an inseparable mixture of diastereomers of 44 (1.32 g, 92%)
as a pale yellow oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 7.77 (d, J =
7.5 Hz, 2H), 7.60 (d, J = 7.5 Hz, 2H), 7.41 (t, J = 7.5 Hz, 2H), 7.32 (t,
J = 7.5 Hz, 2H), 5.90−5.72 (m) and 5.63 (s) (2H), 5.05−4.89 (m,
2H), 4.78−4.70 (m, 1H), 4.46−4.35 (m, 2H), 4.23 (t, J = 7.0 Hz, 1H),
3.56 (s), 3.54 (s), 3.50 (s), and 3.48 (s) (3H), 3.20−2.82 (m, 2H),
2.59−2.46 (m) and 2.18−1.78 (m) (4H), 1.77−1.13 (m, 10H); 13C
NMR (75.5 MHz, CDCl3) δ (ppm) 157.0 (s), 156.7 (s), 144.5 (s),
144.2 (s), 143.8 (s), 143.6 (d), 143.3 (d), 141.5 (s), 139.3 (d), 139.2
(d), 127.7 (d), 127.1 (d), 125.1 (d), 120.0 (d), 119.6 (s), 114.6 (t),
114.4 (t), 114.3 (t), 66.5 (t), 66.1 (t), 59.0 (q), 58.9 (q), 46.9 (d), 45.2
(d), 45.0 (d), 44.5 (t), 44.4 (t), 43.3 (d), 43.2 (d), 43.0 (d), 37.6 (d),
37.4 (d), 32.4 (t), 32.1 (t), 31.9 (t), 31.6 (t), 31.4 (t), 31.0 (t), 30.0
(t), 29.6 (t), 29.4 (t), 29.2 (t), 28.5 (t), 28.3 (t), 27.4 (t), 26.7 (t), 26.1
(t), 25.6 (t), 25.4 (t), 25.0 (t), 24.9 (t), 24.3 (t), 23.5 (t); IR (film) ν
(cm−1) 3420, 3340, 3067, 3008, 2927, 2859, 1722, 1694, 1537, 1519,
1449, 1249, 1124; MS (EI) m/z (rel %): 445 [M+] (1), 178 (100), 151
(20), 148 (18); HRMS (EI) calcd for C29H35NO3 [M
+] 445.2617,
found 445.2626.
N-((2-(But-3-en-1-yl)-3-(methoxymethylene)cycloheptyl)-
methyl)-N-((trimethylsilyl)methyl)formamide (45). NaH (60% in
mineral oil, 143 mg, 3.58 mmol) was added to a solution of 44 (1.06 g,
2.38 mmol) in THF (28 mL) and DMF (14 mL) at rt. The reaction
mixture was stirred at 75 °C for 1 h; then TMSI (530 μL, 3.57 mmol)
was added. The solution was stirred at 75 °C for 3.5 h, and aqueous
NaOH (1 N) was added. The usual workup (Et2O) afforded the
corresponding secondary amine as a yellow oil. The latter was
solubilized in THF (20 mL); then N-formylbenzotriazole (454 mg,
3.09 mmol) was added. The resulting solution was stirred at rt for 15
h. Aqueous NaOH (1 N) was added, and solvent was removed under
reduced pressure. The usual workup (DCM) and purification (0 to 5%
Et2O in DCM) afforded a hardly separable mixture of diastereomers
and rotamers of 45 (485 mg, 60% over 2 steps) as a pale yellow oil.
Only one fraction containing two diastereomers was characterized: 1H
NMR (300 MHz, CDCl3) δ (ppm) 8.06 (s), 8.05 (s), 7.97 (s), and
7.96 (s) (1H), 5.85−5.70 (m) and 5.77 (s) (2H), 5.03−4.89 (m, 2H),
3.56 (s), 3.55 (s), and 3.50 (s) (3H), 3.28−2.93 (m, 2H), 2.88−2.70
(m), 2.85 (d, J = 14.0 Hz), and 2.75 (d, J = 15.0 Hz) (2H), 2.61−2.50
(m) and 2.22−1.09 (m) (14H), 0.11 (s) and 0.09 (s) (9H); 13C NMR
(75.5 MHz, CDCl3) δ (ppm) 163.0, 162.4, 143.9, 143.6, 139.6, 139.4,
139.2, 139.0, 120.2, 119.6, 115.0, 114.7, 114.4, 59.2, 58.9, 53.3, 52.9,
47.6, 47.2, 43.1, 42.4, 41.8, 41.5, 39.9, 37.9, 37.4, 36.8, 36.5, 33.2, 33.0,
32.2, 32.0, 31.9, 31.7, 29.3, 29.1, 28.5, 28.3, 27.0, 26.6, 26.5, 25.7, 25.5,
25.2, 24.8, 24.6, 24.3, −1.9, −2.4; IR (film) ν (cm−1) 2931, 2869, 1664,
1646, 1452, 1249, 853; MS (EI) m/z (rel %): 337 [M+] (1), 322 [M+
− CH3] (100), 306 (23), 151 (66); HRMS (IE) calcd for
C18H32NO2Si [M
+ − CH3] 322.2202, found: 322.2207.
N-((2-(But-3-en-1-yl)-3-formylcycloheptyl)methyl)-N-
((trimethylsilyl)methyl)formamide (46). Trichloroacetic acid (1.38
g, 8.45 mmol) was added to a solution of 45 (569 mg, 1.69 mmol) in
DCM (45 mL). Water (3−4 drops) was added, and the resulting
solution was stirred for 15 h at rt. Saturated aqueous NaHCO3 and
saturated aqueous NaCl were added. The usual workup (DCM) and
purification (30% EtOAc in hexanes) afforded a mixture of
diastereomers and rotamers of 46 (448 mg, 82%) as a colorless oil,
separable in two different portions for characterization: Portion 1: 1H
NMR (300 MHz, CDCl3) δ (ppm) 9.72 (s), 9.63 (s), and 9.62 (s)
(1H), 8.07 (s), 8.00 (s), and 7.98 (s) (1H), 5.85−5.71 (m, 1H), 5.08−
4.91 (m, 2H), 3.43 (dd, J = 13.5, 8.0 Hz), 3.14 (dd, J = 14.0, 7.0 Hz),
and 3.05 (dd, J = 14.0, 7.5 Hz) (2H), 2.86 (s), 2.79 (d, J = 9.0 Hz),
and 2.72 (d, J = 7.5 Hz) (2H), 2.52−2.46 (m, 1H), 2.18−1.20 (m,
14H), 0.11 (s) and 0.09 (s) (9H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 205.6, 205.0, 163.3, 162.4, 138.7, 138.1, 115.8, 115.2, 53.4, 53.2,
47.4, 37.7, 35.8, 34.9, 33.4, 31.8, 31.6, 28.6, 27.3, 27.1, 26.8, 26.5, 26.1,
25.5, 24.6, 24.3, −1.9, −2.4; IR (film) ν (cm−1) 2929, 2856, 1721,
1667, 1452, 1390, 1249; MS (EI) m/z (rel %): 323 [M+] (2), 308 [M+
− CH3] (92), 294 [M+ − CHO] (44), 282 (55), 145 (100); HRMS
(IE) calcd for C18H33NO2Si [M
+] 323.2280, found: 323.2290. Portion
2: 1H NMR (300 MHz, CDCl3) δ (ppm) 9.77 (s), 9.72 (s), and 9.62
(s) (1H), 8.08 (s), 8.06 (s), 8.00 (s), and 7.98 (s) (1H), 5.82−5.63
(m, 1H), 5.06−4.93 (m, 2H), 3.39−2.96 (m), 3.32 (t, J = 8.0 Hz), 3.20
(dd, J = 14.0, 6.5 Hz), and 3.10 (dd, J = 14.0, 8.0 Hz) (2H), 2.85 (d, J
= 15.0 Hz), 2.79 (d, J = 15.5 Hz), 2.75 (s), and 2.55−2.47 (m) (2H),
2.38−2.20 (m) and 2.17−0.85 (m) (15H), 0.13 (s), 0.11 (s), and 0.10
(s) (9H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 205.8, 205.6, 205.1,
163.1, 162.6, 162.4, 138.6, 138.1, 138.0, 115.7, 115.3, 57.1, 54.5, 54.1,
53.9, 49.0, 42.7, 42.4, 41.3, 38.6, 38.0, 37.7, 37.1, 34.2, 33.8, 32.9, 28.7,
28.5, 28.0, 27.7, 26.9, 25.2, 25.0, 24.6, 23.0, −1.8, −2.4; IR (film) ν
(cm−1) 3075, 2931, 2861, 1721, 1666, 1443, 1390, 1249; MS (EI) m/z
(rel %): 323 [M+] (2), 308 [M+ − CH3] (33), 294 [M+ − CHO] (23),
145 (100); HRMS (EI) calcd for C18H33NO2Si [M
+] 323.2280, found:
323.2287.
N-((2-(But-3-en-1-yl)-3-(((tert-butyldimethylsilyl)oxy)methyl-
ene)cycloheptyl)methyl)-N-((trimethylsilyl)methyl)formamide
(47). Following the procedure used to prepare 40, a solution of 46
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(228 mg, 0.705 mmol) in DCM (12 mL) was treated with
TBDMSOTf (260 μL, 1.13 mmol) and i-Pr2NEt (197 μL, 1.13
mmol) for 20 h at rt to afford, after the usual purification using silica
gel saturated with Et3N (10% EtOAc in hexanes), an inseparable
mixture of diastereomers and rotamers of 47 (184 mg, 60%) as a pale
yellow oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 8.08 (s), 8.05 (s),
8.03 (s), 7.97 (s), 7.97 (s), and 7.95 (s) (1H), 6.07 (s) and 5.92 (s)
(1H), 5.85−5.70 (m, 1H), 5.03−4.89 (m, 2H), 3.32 (dd, J = 13.5, 7.5
Hz), 3.21 (dd, J = 13.5, 8.0 Hz), 3.17−2.57 (m), 3.12 (dd, J = 14.0, 7.5
Hz), 3.00 (dd, J = 14.0, 7.5 Hz), 2.86 (d, J = 15.0 Hz), 2.73 (d, J = 15.0
Hz), and 2.51 (d, J = 15.0 Hz) (4H), 2.17−1.06 (m, 14H), 0.92 (s)
and 0.91 (s) (9H), 0.12 (s), 0.10 (s), 0.09 (s), and 0.08 (s) (15 H);
13C NMR (75.5 MHz, CDCl3) δ (ppm) 163.1, 162.6, 162.4, 162.2,
139.7, 139.6, 139.3, 139.1, 136.4, 136.2, 136.0, 135.8, 123.9, 123.3,
122.0, 121.5, 115.0, 114.7, 114.6, 114.3, 54.2, 53.6, 53.0, 47.6, 45.0,
44.6, 43.0, 42.3, 41.8, 41.7, 41.5, 39.6, 37.7, 37.0, 33.8, 33.3, 33.1, 32.4,
32.2, 31.9, 31.7, 31.5, 29.3, 28.5, 28.4, 27.9, 27.2, 26.9, 26.6, 25.8, 25.5,
25.4, 24.8, 24.7, 23.6, 17.9, −1.8, −1.9, −2.4, −5.8; MS (EI) m/z (rel
%): 437 [M+] (2), 422 [M − CH3]+ (23), 380 [M+ − C4H9] (100),
251 (49); HRMS (EI) calcd for C24H47NO2Si2 [M
+] 437.3145, found
437.3138.
rel-(1S,6S)-10-(But-3-en-1-yl)-1-formyl-8-((trimethylsilyl)-
methyl)-8-aza-bicyclo[4.3.1]dec-8-en-8-ium Trifluoromethane-
sulfonate (49). Tf2O (12 μL, 73 μmol) was added to a solution of 47
(29 mg, 66 μmol) and DTBMP (15 mg, 73 μmol) in DCE (0.75 mL)
at rt. After 15 min, additional DCE (7.5 mL) and DMAD (24 μL, 0.20
mmol) were added. Then, the solution was heated at 55 °C for 3 h. 1H
NMR analysis of an aliquot showed the formation of the iminium ion
49: 1H NMR (300 MHz, CDCl3) characteristic signals δ (ppm) 9.70
(s) and 9.63 (s) (1H), 8.46 (s, 1H), 5.83−5.69 (m, 1H), 5.02 (d, J =
10.0 Hz, 1H), 5.01 (d, J = 18.0 Hz, 1H), 3.94−3.77 (m, 1H), 3.45−
3.31 (m, 1H), 3.14−3.08 (m) and 2.60−2.53 (m) (2H), 2.17−1.18
(m, 14H), 0.16 (s, 9H).
2-(((2-(But-3-en-1-yl)-3-(methoxymethylene)cycloheptyl)-
methyl)amino)acetonitrile (56). NaH (60% in mineral oil, 237 mg,
5.92 mmol) was added to a solution of 44 (1.32 g, 2.96 mmol) in THF
(34 mL) and DMF (17 mL) at rt. The mixture was stirred at 75 °C for
1 h; then BrCH2CN (395 μL, 5.92 mmol) was added. The resulting
solution was stirred at 75 °C for 2 h, and saturated aqueous NaHCO3
was added. The usual workup (EtOAc) and purification using silica gel
saturated with Et3N (10 to 40% EtOAc in hexanes) afforded an
inseparable mixture of diastereomers of 56 (683 mg, 88%) as an
orange oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 5.91 (s), 5.88−5.73
(m), 5.80 (s), 5.75 (s), and 5.64 (s) (2H), 5.00 (d, J = 17.5 Hz, 1H),
4.95 (d, J = 10.5 Hz, 1H), 3.61 (s), 3.58 (s), 3.56 (s), 3.55 (s), and
3.51 (s) (5H), 2.66 (dd, J = 11.5, 6.5 Hz) and 2.58−2.49 (m) (3H),
2.18−2.00 (m, 3H), 1.92−1.79 (m, 1H), 1.73−1.06 (m, 10H); 13C
NMR (100 MHz, CDCl3) δ (ppm) 144.2, 143.2, 142.9, 142.8, 138.8,
138.8, 138.6, 138.5, 119.7, 119.3, 119.3, 119.2, 117.7, 117.7, 114.0,
113.8, 113.7, 58.9, 58.8, 58.7, 58.6, 53.4, 53.4, 52.4, 52.3, 44.9, 44.8,
44.4, 43.5, 43.0, 42.6, 38.1, 37.2, 37.1, 37.0, 36.7, 36.7, 32.5, 32.2, 32.0,
31.7, 31.6, 31.5, 31.3, 30.5, 29.9, 29.8, 29.7, 29.1, 28.6, 28.2, 28.0, 27.3,
27.0, 26.4, 25.6, 25.5, 25.3, 24.5, 24.2, 23.5; IR (film) ν (cm−1) 2927,
2854, 1663, 1459, 1222, 1124; MS (CI:NH3) m/z (rel %): 262 [M
+]
(8), 220 (27), 161 (35), 148 (100); HRMS (CI:NH3) calcd for
C16H26N2O [M
+] 262.2045, found: 262.2045.
N-((2-(But-3-en-1-yl)-3-(methoxymethylene)cycloheptyl)-
methyl)-N-(cyanomethyl)formamide (57). N-Formylbenzotriazole
(288 mg, 1.96 mmol) was added to a solution of 56 (427 mg, 1.63
mmol) in THF (22 mL). The resulting mixture was stirred at rt for 18
h. Aqueous NaOH (2 N) was added, and solvent was removed under
reduced pressure. The usual workup (DCM) and purification (30 to
40% EtOAc in hexanes) afforded an inseparable mixture of
diastereomers and rotamers of 57 (415 mg, 88%) as a pale yellow
oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 8.09 (s), 7.98 (s), 7.96 (s),
and 7.94 (s) (1H), 5.87 (s), 5.83−5.51 (m), 5.76 (s), and 5.59 (s)
(2H), 5.04−4.79 (m, 2H), 4.33−4.03 (m, 2H), 3.49 (s), 3.48 (s), 3.47
(s), and 3.44 (s) (3H), 3.34−3.02 (m, 2H), 2.53−2.38 (m, 1H), 2.14−
1.08 (m, 13H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 162.8, 162.5,
162.3, 162.1, 144.9, 143.9, 143.7, 143.4, 138.6, 138.5, 138.1, 118.1,
118.0, 114.9, 114.7, 114.5, 114.4, 59.1, 58.9, 52.2, 51.1, 46.1, 44.5, 42.9,
42.2, 41.9, 41.0, 37.7, 35.8, 32.8, 32.3, 31.8, 31.6, 31.4, 31.3, 30.1, 28.9,
28.5, 28.4, 28.3, 27.2, 26.7, 26.4, 26.2, 25.9, 25.5, 24.7, 23.7; IR (film) ν
(cm−1) 2929, 2863, 1681, 1429, 1223, 1179, 1123; MS (EI) m/z (rel
%): 290 [M+] (2), 275 [M+ − CH3] (4), 206 (26), 174 (34), 148
(100); HRMS (EI) calcd for C17H26N2O2 [M
+] 290.1994, found:
290.1995.
N-((2-(But-3-en-1-yl)-3-formylcycloheptyl)methyl)-N-(cyano-
methyl)formamide (58). Trichloroacetic acid (1.16 g, 7.11 mmol)
was added to a solution of 57 (413 mg, 1.42 mmol) in DCM (36 mL).
Water (4−5 drops) was added, and the resulting solution was stirred
for 18 h at rt. Saturated aqueous NaHCO3 and saturated aqueous
NaCl were added. The usual workup (DCM) and purification (80 to
100% Et2O in hexanes) afforded a mixture of diastereomers and
rotamers of 58 (315 mg, 80%) as a pale yellow oil separable in two
different portions for characterization: Portion 1: 1H NMR (400 MHz,
CDCl3) δ (ppm) 9.76 (s) and 9.61 (s) (1H), 8.14 (s), 8.04 (s), and
7.99 (s) (1H), 5.79−5.63 (m, 1H), 5.02−4.89 (m, 2H), 4.69 (d, J =
17.5 Hz), 4.39 (d, J = 18.0 Hz), 4.34 (d, J = 17.5 Hz), 4.30 (d, J = 18.0
Hz), 4.15 (d, J = 17.5 Hz), and 4.14 (d, J = 17.5 Hz) (2H), 3.79 (dd, J
= 14.0, 10.0 Hz), 3.35 (dd, J = 7.0, 5.5 Hz), 3.27 (dd, J = 14.5, 8.5 Hz),
3.20 (dd, J = 14.5, 7.0 Hz), and 2.98 (dd, J = 14.0, 6.0 Hz) (2H),
2.57−2.48 (m, 1H), 2.14−1.97 (m, 3H), 1.93−1.78 (m, 3H), 1.68−
1.52 (m, 3H), 1.50−1.31 (m, 5H); 13C NMR (100 MHz, CDCl3) δ
(ppm) 206.4, 205.9, 205.5, 163.3, 162.9, 162.8, 138.5, 137.8, 137.7,
116.0, 115.9, 115.2, 115.0, 53.7, 52.8, 52.7, 52.6, 51.0, 44.9, 41.7, 36.4,
35.1, 34.3, 34.1, 34.1, 33.8, 31.6, 31.3, 31.1, 29.9, 29.4, 27.9, 27.7, 26.8,
26.4, 26.3, 26.3, 26.0, 25.8, 25.7, 25.5, 25.4, 24.4, 24.0, 23.9; IR (film) ν
(cm−1) 2930, 2863, 1719, 1680, 1432, 1399; MS (EI) m/z (rel %):
276 [M+] (9), 247 [M-CHO]+ (10), 233 [M+ − CH2CN] (8), 192
(57), 137 (62), 95 (100); HRMS (EI) calcd for C16H24N2O2 [M
+]
276.1838, found: 276.1836. Portion 2: 1H NMR (400 MHz, CDCl3) δ
(ppm) 9.68 (s) and 9.67 (s) (1H), 8.16 (s) and 8.03 (s) (1H), 5.72−
5.61 (m, 1H), 4.99−4.90 (m, 2H), 4.36 (d, J = 17.5 Hz), 4.22 (d, J =
4.5 Hz), and 4.17 (d, J = 17.5 Hz) (2H), 3.55 (dd, J = 14.0, 8.0 Hz),
3.38 (dd, J = 14.5, 7.5 Hz), 3.30 (dd, J = 14.0, 8.0 Hz), and 3.23 (dd, J
= 14.5, 8.0 Hz) (2H), 2.39−2.23 (m, 2H), 2.07−1.88 (m, 3H), 1.80−
1.49 (m, 7H), 1.44−1.19 (m, 3H); 13C NMR (100 MHz, CDCl3) δ
(ppm) 204.6, 204.1, 162.4, 137.9, 137.4, 115.6, 115.1, 114.9, 114.7,
56.7, 52.8, 47.7, 42.7, 37.8, 37.3, 36.3, 33.1, 33.0, 30.6, 29.0, 28.7, 25.3,
25.1, 24.8, 24.8, 24.7, 24.7, 23.2; IR (film) ν (cm−1) 2931, 2864, 1719,
1679, 1433, 1402, 1181; MS (EI) m/z (rel %): 276 [M+] (8), 247 [M+
− CHO] (9), 233 [M+ − CH2CN] (7), 192 (65), 95 (96), 81 (100);
HRMS (EI) calcd for C16H24N2O2 [M
+] 276.1838, found: 276.1839.
N-((2-(But-3-en-1-yl)-3-(((tert-butyldimethylsilyl)oxy)methyl-
ene)cycloheptyl)methyl)-N-(cyanomethyl)formamide (59). Fol-
lowing the procedure used to prepare 40, a solution of 58 (145 mg,
0.525 mmol) in DCM (9 mL) was treated with TBDMSOTf (193 μL,
0.839 mmol) and i-Pr2NEt (146 μL, 0.839 mmol) for 7 h at rt to
afford, after the usual purification using silica gel saturated with Et3N
(0 to 40% EtOAc in hexanes), a mixture of diastereomers and
rotamers of 59 (113 mg, 55%) as a pale yellow oil separable in two
different portions for characterization: Portion 1: 1H NMR (400 MHz,
CDCl3) δ (ppm) 8.11 (s), 8.04 (s), and 8.01 (s) (1H), 6.24 (s), 6.07
(s), and 6.05 (s) (1H), 5.77 (ddt, J = 17.0, 10.0, 7.0 Hz, 1H), 5.01−
4.88 (m, 2H), 4.58 (d, J = 17.5 Hz), 4.36 (d, J = 17.5 Hz), 4.25 (d, J =
17.5 Hz), 4.15 (d, J = 18.0 Hz), 4.14 (d, J = 17.5 Hz), and 4.10 (d, J =
17.5 Hz) (2H), 3.69 (dd, J = 14.0, 9.5 Hz), 3.39 (dd, J = 14.5, 4.5 Hz),
3.32 (dd, J = 14.5, 8.5 Hz), 3.23 (dd, J = 14.5, 7.5 Hz), and 3.19−3.14
(m) (2H), 2.80 (d, J = 12.0 Hz), 2.75−2.70 (m), and 2.67−2.63 (m)
(1H), 2.19−2.13 (m, 1H), 2.02−1.93 (m, 2H), 1.83−1.45 (m) and
1.42−1.33 (m) (8H), 1.26−1.11 (m, 2H), 0.91 (s) and 0.90 (s) (9H),
0.12 (s) and 0.11 (s) (6H); 13C NMR (100 MHz, CDCl3) δ (ppm)
162.7, 162.2, 161.8, 138.9, 138.8, 138.5, 137.2, 135.9, 135.4, 121.8,
120.8, 114.9, 114.4, 114.3, 52.6, 50.8, 45.2, 41.4, 40.1, 39.9, 38.0, 35.9,
35.7, 35.4, 33.3, 32.4, 32.3, 31.6, 31.5, 30.3, 29.8, 29.7, 29.5, 28.9, 28.7,
28.6, 27.5, 27.3, 27.1, 25.7, 25.4, 25.2, 24.8, 24.4, 18.2, −5.2, −5.4; IR
(film) ν (cm−1) 2960, 2929, 2859, 1687, 1463, 1429, 1387, 1254, 1164,
1141; MS (EI) m/z (rel %): 390 [M+] (1), 333 [M+ − C4H9] (100),
306 (25), 251 (45); HRMS (EI) calcd for C22H38N2O2Si [M
+]
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390.2702, found: 390.2703. Portion 2: 1H NMR (400 MHz, CDCl3) δ
(ppm) 8.14 (s), 8.01 (s), and 8.00 (s) (1H), 6.10 (s), 6.07 (s), and
5.93 (s) (1H), 5.79−5.69 (m, 1H), 4.97 (dd, J = 17.0, 1.5 Hz, 1H),
4.96 (d, J = 10.0 Hz, 1H), 4.22 (s), 4.14 (s), and 4.13 (s) (2H), 3.42
(dd, J = 14.0, 7.5 Hz), 3.35 (dd, J = 14.5, 8.5 Hz), 3.30 (dd, J = 14.5,
7.5 Hz), and 3.19 (dd, J = 14.5, 8.0 Hz) (2H), 2.66−2.58 (m, 1H),
2.09−1.98 (m, 3H), 1.87−1.77 (m, 2H), 1.75−1.66 (m, 2H), 1.63−
1.44 (m, 3H), 1.41−1.22 (m, 3H), 0.91 (s, 9H), 0.11 (s, 6H); 13C
NMR (100 MHz, CDCl3) δ (ppm) 162.4, 162.1, 138.8, 138.3, 136.3,
135.9, 122.6, 121.9, 115.1, 114.6, 114.4, 51.3, 46.4, 43.1, 42.4, 42.2,
42.1, 35.8, 32.0, 31.8, 30.1, 28.7, 28.6, 26.7, 26.5, 26.1, 25.9, 25.7, 25.6,
24.9, 24.8, 18.2, −5.3; IR (film) ν (cm−1) 2953, 2929, 2858, 1685,
1432, 1254, 1164, 1136; MS (EI) m/z (rel %): 390 [M+] (1), 375 [M+
− CH3] (7), 333 [M − C4H9]+ (100), 306 (17), 251 (58); HRMS
(EI) calcd for C22H38N2O2Si [M
+] 390.2702, found: 390.2705.
rel-(1S,6S)-10-(But-3-en-1-yl)-8-(cyanomethyl)-1-formyl-8-
azabicyclo[4.3.1]dec-8-en-8-ium Trifluoromethanesulfonate
(60). Tf2O (13 μL, 77 μmol) was added to a solution of 59 (25
mg, 64 μmol) and DTBMP (14.5 mg, 70.4 μmol) in DCE (1.0 mL) at
rt. After 20 min, the mixture was heated at 80 °C for 3 h. 1H NMR
analysis of an aliquot showed the formation of the iminium ion 60: 1H
NMR (400 MHz, CDCl3) characteristic signals δ (ppm) 9.99 (s) and
9.91 (s) (1H), 9.70 (s) and 9.45 (s) (1H), 6.24−6.05 (m, 1H), 5.90
(d, J = 17.5 Hz), 5.80 (d, J = 17.5 Hz), 5.68 (d, J = 17.5 Hz), and 5.57
(d, J = 17.5 Hz) (2H), 5.46−5.26 (m, 2H), 4.83 (d, J = 5.5 Hz), 4.27
(d, J = 16.0 Hz), 3.87 (d, J = 14.0 Hz), and 3.64 (bs) (2H), 3.20−2.98
(m, 2H), 2.81−1.54 (m, 12H).
N-(Cyanomethyl)-N-(5-methoxypent-4-en-1-yl)formamide
(65). A solution of KHMDS (0.5 M in toluene, 7.68 mL, 3.84 mmol)
was added dropwise to a solution of 649a (499 mg, 3.49 mmol) in
THF (14.0 mL) and DMF (7.0 mL) at rt. The reaction mixture was
stirred for 1 h; then a solution of 18-crown-6 ether (1.01 g, 3.84
mmol) in THF (1.0 mL) and BrCH2CN (345 μL, 5.18 mmol) were
added. The solution was stirred for 18 h at rt; then saturated aqueous
NaHCO3 was added. The usual workup (EtOAc) and purification (60
to 70% EtOAc in hexanes) afforded a mixture of E/Z isomers and
rotamers of 65 (238 mg, 38%) as a brown oil: 1H NMR (400 MHz,
CDCl3) δ (ppm) 8.10 (s), 8,07 (s), and 8.05 (s) (1H), 6.30 (d, J =
12.5 Hz), and 5.95 (d, J = 6.0 Hz) (1H), 4.64 (dt, J = 12.5, 7.5 Hz,
1H), 4.27 (s), 4.26 (s), and 4.17 (s) (2H), 3.58 (s) and 3.50 (s) (3H),
3.48−3.37 (m) and 3.40 (t, J = 7.0 Hz) (2H), 2.07 (q, J = 7.0 Hz) and
1.97 (q, J = 7.0 Hz) (2H), 1.72−1.62 (m, 2H); 13C NMR (100 MHz,
CDCl3) δ (ppm) 162.4 (d), 162.1 (d), 161.8 (d), 147.8 (d), 147.5 (d),
147.2 (d), 115.0 (s), 114.8 (s), 114.7 (s), 103.6 (d), 100.8 (d), 100.3
(d), 59.2 (q), 55.6 (q), 55.5 (q), 46.6 (t), 46.5 (t), 42.2 (t), 35.6 (t),
29.8 (t), 29.7 (t), 28.1 (t), 27.2 (t), 27.1 (t), 24.5 (t), 23.9 (t), 19.9 (t);
IR (film) ν (cm−1) 3059, 2937, 2856, 1681, 1429, 1397, 1209, 1181,
1143, 1108, 934; MS (EI) m/z (rel %): 182 [M+] (10), 152 (9), 98
(100), 85 (29); HRMS (EI) calcd for C9H14N2O2 [M
+] 182.1055,
found 182.1057.
rel-9-(Methoxymethylene)-1,3-dioxo-2-phenyldecahydro-
1H-pyrrolo[3,4-a]indolizine-4-carbonitrile (67). Tf2O (61 μL,
0.36 mmol, freshly distilled over P2O5) was added to a solution of 65
(60 mg, 0.33 mmol) and DTBMP (74 mg, 0.36 mmol) in DCM (5.0
mL) at rt. After 30 min, N-phenylmaleimide (342 mg, 1.97 mmol),
followed by i-Pr2NEt (230 μL, 1.32 mmol), was added at 0 °C. The
mixture was then stirred for 2 h at rt. Saturated aqueous Na2CO3 was
added. The usual workup (DCM) and purification using silica gel
saturated with Et3N (20 to 60% EtOAc in hexanes) afforded two
separable portions of two diastereomers of 67: portion 1 (42 mg, 1.5:1
d.r.) as a yellow oil and portion 2 (34 mg, 2:1 d.r.) as a brown oil (79%
global yield). Portion 1 (two diastereomers): 1H NMR (300 MHz,
CDCl3) δ (ppm) 7.49−7.36 (m, 3H), 7.27−7.18 (m, 2H), 6.78 (s)
and 6.36 (s) (1H), 4.41 (s), 3.80 (dd, J = 9.5, 6.0 Hz), and 3.64−3.49
(m) (3H), 3.65 (s) and 3.62 (s) (3H), 3.47−3.42 (m) and 3.39−3.31
(m) (1H), 3.04−2.76 (m, 2H), 2.45 (td, J = 11.0, 2.5 Hz) and 2.32
(td, J = 11.0, 3.5 Hz) (1H), 1.79−1.60 (m) and 1.58−1.46 (m) (3H);
13C NMR (75.5 MHz, CDCl3) δ (ppm) 175.0, 174.6, 174.4, 174.2,
145.9, 143.3, 131.9, 131.4, 129.6, 129.5, 129.3, 126.7, 126.5, 117.7,
115.4, 111.8, 108.4, 66.2, 63.4, 59.8, 59.6, 56.9, 54.7, 50.5, 48.8, 48.5,
48.1, 45.7, 45.1, 23.8, 23.0, 22.4, 21.5; IR (film) ν (cm−1) 3019, 2942,
2831, 1716, 1498, 1386, 1181, 1129; MS (EI) m/z (rel %): 392 (21),
360 [MNa+] (100), 333 (35); HRMS (EI) calcd for C19H19N3O3Na
[MNa+] 360.1319, found 360.1327. Portion 2 (two diastereomers): 1H
NMR (300 MHz, CDCl3) δ (ppm) 7.52−7.38 (m, 3H), 7.33−7.21
(m, 2H), 6.80 (s) and 6.25 (s) (1H), 4.44 (d, J = 8.5 Hz), 3.79 (t, J =
9.0 Hz), and 3.60−3.24 (m) (4H), 3.63 (s, 3H), 3.08−2.99 (m) and
2.94−2.81 (m) (2H), 2.65 (td, J = 11.5, 2.5 Hz) and 2.03 (t, J = 11.0
Hz) (1H), 1.84−1.50 (m, 3H); 13C NMR (75.5 MHz, CDCl3) δ
(ppm) 174.9, 174.1, 173.5, 173.4, 145.8, 143.1, 131.9, 131.6, 129.6,
129.5, 129.4, 129.2, 126.9, 126.9, 115.4, 113.9, 112.4, 108.3, 66.4, 63.3,
59.8, 59.7, 56.9, 55.3, 51.4, 48.7, 46.8, 46.1, 45.5, 44.8, 23.6, 23.2, 22.3,
21.8; IR (film) ν (cm−1) 3019, 2939, 2836, 1717, 1499, 1384, 1194,
1130; MS (EI) m/z (rel %): 392 (22), 360 [MNa+] (100), 333 (29);
HRMS (EI) calcd for C19H19N3O3Na [MNa
+] 360.1319, found
360.1327.
N-(rel-(2S,3S)-2-Allyl-3-(2-(allyloxy)vinyl)-6-(benzyloxy)-
hexyl)formamide (76). TBAI (1.51 g, 4.09 mmol) and diformyl-
imide sodium salt (1.16 g, 12.3 mmol) were added to a solution of 758
(1.61 g, 4.09 mmol) in DMF (41 mL). The solution was stirred at 50
°C for 24 h and then cooled at rt. 5% NaOH solution in MeOH (6.0
mL) was added, and the mixture was stirred at rt for 45 min. The usual
workup (Et2O) and purification using silica gel saturated with Et3N
(10 to 80% EtOAc in hexanes) afforded 76 (1.13 g, 78%) as a colorless
oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 8.10 (d, J = 1.5 Hz), 7.96
(d, J = 12.0 Hz), and 7.92 (d, J = 12.0 Hz) (1H), 7.37−7.25 (m, 5H),
6.17 (d, J = 12.5 Hz), 6.16 (d, J = 12.5 Hz), 6.10 (d, J = 5.0 Hz), and
6.08 (d, J = 6.0 Hz) (1H), 5.97−5.87 (m, 1H), 5.87−5.68 (m, 1H),
5.55 (bs, 1H), 5.35−5.21 (m, 2H), 5.09−5.02 (m, 2H), 4.56−4.46
(m), 4.49 (s), and 4.27−4.07 (m) (5H), 3.63 (ddd, J = 13.0, 8.0, 4.5
Hz), 3.48−3.34 (m), and 3.31−3.00 (m) (4H), 2.58−2.44 (m) and
2.22−1.86 (m) (3H), 1.71−1.13 (m, 5H); 13C NMR (75.5 MHz,
CDCl3) δ (ppm) 164.7 (d), 161.2 (d), 146.9 (d), 146.7 (d), 145.5 (d),
145.4 (d), 138.2 (s), 136.6 (d), 136.5 (d), 136.4 (d), 136.0 (d), 133.4
(d), 133.2 (d), 128.0 (d), 127.3 (d), 127.2 (d), 117.6 (t), 117.2 (t),
117.1 (t), 116.9 (t), 116.7 (t), 116.4 (t), 116.2 (t), 108.6 (d), 108.4
(d), 104.9 (d), 104.4 (d), 72.5 (d), 72.3 (d), 70.0 (d), 69.8 (d), 69.6
(d), 43.3 (d), 42.5 (d), 42.4 (d), 42.0 (t), 39.1 (d), 38.7 (d), 38.5 (t),
38.4 (t), 35.0 (d), 34.7 (d), 34.2 (t), 33.9 (t), 33.4 (t), 33.0 (t), 29.2
(t), 29.1 (t), 28.9 (t), 27.5 (t), 27.3 (t), 27.1 (t); IR (film) ν (cm−1)
3299, 3066, 3028, 2930, 2858, 1665, 1536, 1453, 1385, 1163, 1100;
MS (CI: NH3) m/z (rel %): 316 [M
+ − C3H5] (30), 208 (35), 163
(100); HRMS (CI: NH3) calcd for C22H32NO3 [MH
+] 358.2382,
found 358.2390.
(((4-(2-(Allyloxy)vinyl)-5-methyleneoct-7-en-1-yl)oxy)-
methyl)benzene (77). NaH (60% in mineral oil, 24 mg, 0.58 mmol)
was added to a solution of formamide (770 μL, 19.2 mmol) in THF
(1.5 mL) and DMF (0.7 mL) at 0 °C. The solution was stirred for 1 h
at rt; then NaI (72 mg, 0.48 mmol) and a solution of 75 (175 mg,
0.445 mmol) in THF (1.5 mL) were added. The mixture was stirred
for 48 h at 80 °C; then water was added. The usual workup (EtOAc)
and purification using silica gel saturated with Et3N (0 to 60% EtOAc
in hexanes) afforded 76 (56 mg, 35%) as a colorless oil and 77 (78 mg,
56%) as a colorless oil: 77: 1H NMR (300 MHz, CDCl3) δ (ppm)
7.38−7.24 (m, 5H), 6.22 (d, J = 12.5 Hz) and 6.00 (d, J = 6.5 Hz)
(1H), 5.97−5.73 (m, 2H), 5.32 (dd, J = 17.0, 1.5 Hz), 5.29 (dd, J =
17.5, 1.5 Hz), 5.23 (dd, J = 8.0, 1.0 Hz), and 5.20 (dd, J = 10.5, 1.5
Hz) (2H), 5.08 (m, 2H), 4.84−4.83 (m) and 4.77−4.75 (m) (2H),
4.66 (dd, J = 12.5, 9.0 Hz) and 4.27−4.18 (m) (3H), 4.50 (s, 2H),
3.47 (td, J = 6.0, 5.0 Hz, 2H), 3.24 (td, J = 9.5, 4.5 Hz) and 2.55−2.47
(m) (1H), 2.77 (t, J = 7.5 Hz, 2H), 1.70−1.35 (m, 4H); 13C NMR
(75.5 MHz, CDCl3) δ (ppm) 151.1 (s), 150.9 (s), 146.1 (d), 144.7
(d), 138.6 (s), 138.5 (s), 136.6 (d), 136.5 (d), 133.9 (d), 133.4 (d),
128.2 (d), 127.5 (d), 127.3 (d), 117.2 (t), 116.8 (t), 116.1 (t), 115.9
(t), 109.8 (d), 109.5 (t), 108.9 (t), 107.4 (d), 72.7 (t), 72.4 (t), 70.3
(t), 70.2 (t), 69.8 (t), 44.3 (d), 40.0 (d), 39.0 (t), 38.6 (t), 30.3 (t),
30.1 (t), 27.6 (t), 27.5 (t); IR (film) ν (cm−1) 3081, 3032, 2982, 2940,
2856, 1661, 1643, 1454; MS (EI) m/z (rel %): 312 [M+] (2), 221 (8),
163 (100), 91 (100); HRMS (EI) calcd for C21H28O2 [M
+] 312.2089,
found 312.2084
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Ethyl 2-(N-(rel-(2S,3S)-2-Allyl-3-(2-(allyloxy)vinyl)-6-(benzyl-
oxy)hexyl)formamido)acetate (78). NaH (60% in mineral oil,
190 mg, 4.74 mmol) was added to a solution of 76 (1.13 g, 3.16
mmol) in THF (7.0 mL) and DMF (2.5 mL) at rt, and the solution
was stirred for 1 h. BrCH2CO2Et (525 μL, 4.74 mmol) was added.
The mixture was stirred for 18 h at rt; then water was added and THF
was removed under reduced pressure. The usual workup (EtOAc) and
purification (20 to 80% EtOAc in hexanes) afforded 78 (1.32 g, 94%)
as a colorless oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 8.07 (s), 8.07
(s), and 8.06 (s) (1H), 7.37−7.25 (m, 5H), 6.16 (d, J = 12.5 Hz) and
6.06 (d, J = 6.5 Hz) (1H), 5.99−5.57 (m, 2H), 5.35−5.18 (m, 2H),
5.07−4.98 (m, 2H), 4.48 (s, 2H), 4.52−4.43 (m) and 4.22−3.84 (m)
(7H), 3.44 (t, J = 6.0 Hz) and 3.43 (t, J = 6.0 Hz) (2H), 3.39−3.29
(m) and 3.23−3.06 (m) (2H), 2.67−2.59 (m), 2.25−2.22 (m), and
2.11−1.94 (m) (3H), 1.71−1.41 (m, 4H), 1.30−1.24 (m, 4H); 13C
NMR (75.5 MHz, CDCl3) δ (ppm) 168.9 (s), 168.2 (s), 168.1 (s),
163.6 (d), 163.3 (d), 163.2 (d), 147.3 (d), 147.0 (d), 146.0 (d), 145.7
(d), 138.4 (s), 138.2 (s), 136.7 (d), 136.5 (d), 135.7 (d), 133.6 (d),
133.1 (d), 128.1 (d), 127.3 (d), 117.2 (t), 117.1 (t), 116.9 (t), 116.4
(t), 116.0 (t), 107.6 (d), 107.3 (d), 104.0 (d), 72.6 (t), 72.4 (t), 72.2
(t), 70.1 (t), 69.9 (t), 69.8 (t), 69.7 (t), 61.4 (t), 61.3 (t), 61.1 (t), 61.0
(t), 48.9 (t), 48.5 (t), 44.1 (t), 44.0 (t), 43.8 (t), 43.6 (t), 40.4 (d),
40.3 (d), 40.0 (d), 39.9 (d), 38.7 (d), 38.1 (d), 34.2 (d), 33.9 (d), 33.7
(t), 33.6 (t), 33.2 (t), 33.1 (t), 28.9 (t), 28.2 (t), 27.7 (t), 27.6 (t), 27.3
(t), 13.8 (q); IR (film) ν (cm−1) 3073, 3035, 2986, 2936, 2861, 1749,
1679, 1453, 1435, 1197, 1098; MS (CI: NH3) m/z (rel %): 444
[MH+] (100), 416 (13), 402 (16), 358 (23); HRMS (CI: NH3) calcd
for C26H38NO5 [MH
+] 444.2750, found 444.2757.
Ethyl 2-(N-(rel-(2S,3S)-2-Allyl-3-(3-(benzyloxy)propyl)-4-
formylhept-6-en-1-yl)formamido)acetate (79). A solution of 78
(703 mg, 1.58 mmol) in toluene (31 mL) was heated at 150 °C in a
sealed tube for 96 h. The solution was concentrated under reduced
pressure to afford an inseparable mixture of diastereomers and
rotamers of 79 (703 mg, 100%) as a pale yellow oil: 1H NMR (400
MHz, CDCl3) δ (ppm) 9.70−9.61 (m, 1H), 8.08 (s) and 8.06 (s)
(1H), 7.40−7.24 (m, 5H), 5.76−5.59 (m, 2H), 5.11−4.98 (m, 4H),
4.49 (s, 2H), 4.23−4.16 (m, 2H), 4.03 (d, J = 17.5 Hz), 4.01 (d, J =
17.5 Hz), 3.95−3.80 (m), 3.90 (d, J = 17.5 Hz), and 3.87 (d, J = 17.5
Hz) (2H), 3.60−3.38 (m), 3.31−3.17 (m), and 3.15−3.07 (m) (4H),
2.56−2.39 (m, 2H), 2.31−1.85 (m, 4H), 1.83−1.38 (m, 5H), 1.31−
1.22 (m, 3H); 13C NMR (100 MHz, CDCl3) δ (ppm) 205.8 (d),
205.5 (d), 205.4 (d), 205.0 (d), 169.6 (s), 168.9 (s), 164.6 (d), 164.5
(d), 164.0 (d), 164.0 (d), 138.9 (s), 138.7 (s), 136.7 (d), 136.6 (d),
136.0 (d), 135.9 (d), 135.9 (d), 135.4 (d), 135.4 (d), 128.7 (d), 128.7
(d), 128.0 (d), 127.8 (d), 118.0 (t), 117.9 (t), 117.9 (t), 117.7 (t),
117.5 (t), 117.3 (t), 117.3 (t), 117.3 (t), 72.9 (t), 72.8 (t), 72.8 (t),
70.2 (t), 70.1 (t), 69.6 (t), 69.5 (t), 61.7 (t), 61.3 (t), 61.3 (t), 52.6
(d), 52.5 (d), 49.5 (t), 49.4 (t), 48.8 (t), 48.7 (t), 44.8 (t), 44.6 (t),
43.9 (t), 43.9 (t), 38.1 (d), 37.7 (d), 37.4 (d), 37.1 (d), 36.9 (d), 36.6
(d), 33.0 (t), 32.9 (t), 32.5 (t), 32.5 (t), 31.4 (t), 31.1 (t), 30.8 (t),
30.7 (t), 28.6 (t), 28.4 (t), 28.4 (t), 28.2 (t), 23.9 (t), 23.7 (t), 23.5 (t),
13.6(q); IR (film) ν (cm−1) 3073, 2982, 2936, 2864, 1748, 1720, 1678,
1436, 1400, 1198; MS (EI) m/z (rel %): 443 [M+] (3), 398 [M −
OC2H5]
+ (7), 342 (36), 264 (33), 116 (90), 91 (100); HRMS (EI)
calcd for C26H37NO5 [M
+] 443.2672, found 443.2661.
Ethyl 2-(N-((rel-(1S,7S)-7-(3-(Benzyloxy)propyl)-6-formyl-
cyclohept-3-en-1-yl)methyl)formamido)acetate (80). Second-
generation Grubbs’ catalyst (40 mg, 5 mol %) was added to a
solution of 79 (423 mg, 0.954 mmol) in DCM (160 mL). The
solution was stirred for 18 h at rt and then concentrated under reduced
pressure. The usual purification (50% EtOAc in hexanes) afforded a
mixture of diastereomers and rotamers of 80 (344 mg, 87%) as a
brown oil: 1H NMR (400 MHz, CDCl3) δ (ppm) 9.72 (s), 9.70 (s),
9.62 (s), and 9.61 (s) (1H), 8.11 (s), 8.07 (s), and 8.05 (s) (1H),
7.42−7.23 (m, 5H), 5.78−5.56 (m, 2H), 4.48 (s) and 4.45 (s) (2H),
4.24−4.11 (m), 4.07 (s), 3.98 (d, J = 17.0 Hz), 3.95 (s), and 3.90 (d, J
= 17.0 Hz) (4H), 3.52−3.12 (m, 4H), 2.62−2.34 (m) and 2.33−2.16
(m) (4H), 2.12−1.77 (m, 3H), 1.71−1.30 (m, 4H), 1.28−1.22 (m,
3H); 13C NMR (100 MHz, CDCl3) δ (ppm) 205.8 (d), 205.1 (d),
204.9 (d), 204.6 (d), 169.7 (s), 169.7 (s), 168.9 (s), 168.9 (s), 164.4
(d), 164.3 (d), 163.9 (d), 163.8 (d), 138.8 (s), 138.7 (s), 131.3 (d),
130.8 (d), 129.2 (d), 129.0 (d), 128.7 (d), 128.6 (d), 128.6 (d), 128.6
(d), 128.5 (d), 128.3 (d), 127.9 (d), 127.9 (d), 127.8 (d), 127.8 (d),
127.7 (d), 72.9 (t), 72.8 (t), 72.7 (t), 72.6 (t), 70.2 (t), 70.2 (t), 69.6
(t), 69.6 (t), 61.7 (t), 61.6 (t), 61.3 (t), 61.2 (t), 56.6 (d), 56.3 (d),
52.4 (t), 51.7 (d), 51.6 (d), 51.0 (t), 49.2 (t), 48.2 (t), 47.9 (t), 46.0
(t), 44.4 (t), 43.5 (t), 41.9 (d), 41.6 (d), 38.6 (d), 38.0 (d), 37.2 (d),
37.1(d), 34.3 (d), 34.2 (d), 28.5 (t), 28.2 (t), 28.1 (t), 28.0 (t), 27.5
(t), 27.0 (t), 27.0 (t), 26.9 (t), 23.7 (t), 23.6 (t), 23.4 (t), 23.2 (t), 22.6
(t), 22.4 (t), 20.7 (t), 20.6 (t), 13.6 (q), 13.6 (q); IR (film) ν (cm−1)
2986, 2938, 2869, 1746, 1720, 1676, 1439, 1401, 1371, 1203; MS (EI)
m/z (rel %): 416 [MH+] (17), 402 (10), 388 (45), 218 (100); HRMS
(EI) calcd for C24H33NO5 [M
+] 415.2359, found 415.2361.
Ethyl 2-(N-((rel-(1S,7S)-7-(3-(Benzyloxy)propyl)-6-(((tert-
butyldimethylsilyl)oxy)methylene)cyclohept-3-en-1-yl)-
methyl)formamido)acetate (81). Following the procedure used to
prepare 40, a solution of 80 (49 mg, 0.12 mmol) in DCM (2.0 mL)
was treated with TBDMSOTf (65 μL, 0.28 mmol) and i-Pr2NEt (49
μL, 0.28 mmol) for 18 h at rt to afford, after the usual purification
using silica gel saturated with Et3N (0 to 40% EtOAc in hexanes), one
geometrical isomer of 81 (as a mixture of rotamers) of unidentified
stereochemistry (48 mg, 76%) as a colorless oil: 1H NMR (400 MHz,
C6D6) δ (ppm) 7.96 (s) and 7.81 (s) (1H), 7.43−7.32 (m, 2H), 7.27−
7.07 (m, 3H), 6.23 (s, 1H), 5.81−5.73 (m, 1H), 5.58−5.44 (m, 1H),
4.42−4.34 (AB quartet, 2H), 3.95−3.79 (m), 3.72 (d, J = 17.0 Hz),
and 3.46−3.22 (m) (7H), 3.55 (dd, J = 14.0, 7.0 Hz), 3.12 (dd, J =
14.0, 7.5 Hz), 2.85 (dd, J = 14.5, 7.5 Hz), and 2.76−2.62 (m) (3H),
2.21−2.12 (m, 1H), 1.84−1.31 (m, 6H), 1.28−1.15 (m, 1H), 0.94 (s,
9H), 0.88 (t, J = 7.0 Hz, 3H), 0.07 (s, 6H); 13C NMR (100 MHz,
C6D6) δ (ppm) 169.5 (s), 168.8 (s), 163.6 (d), 163.4 (d), 139.8 (s),
139.5 (s), 135.2 (d), 134.8 (d), 129.7 (d), 129.5 (d), 128.6 (d), 128.5
(d), 128.3 (d), 128.2 (d), 128.0 (d), 127.8 (d), 127.7 (d), 127.5 (d),
122.2 (s), 121.1 (s), 72.7 (t), 72.5 (t), 70.3 (t), 69.5 (t), 60.8 (t), 60.6
(t), 50.7 (t), 48.2 (t), 46.6 (t), 44.0 (t), 43.9 (t), 42.7 (d), 40.5 (d),
40.1 (d), 28.6 (t), 28.2 (t), 27.6 (t), 27.2 (t), 25.4 (q), 25.2 (q), 24.6
(t), 24.5 (t), 21.6 (t), 21.2 (t), 17.8 (s), 13.3 (q), −6.1 (q), −6.1 (q);
IR (film) ν (cm−1) 3024, 2952, 2930, 2857, 1751, 1682, 1435, 1253,
1198, 838; MS (ESI) m/z (rel %): 552 [MNa+] (100); HRMS (ESI)
calcd for C30H47NO5SiNa [MNa
+] 552.3116, found 552.3127.
Ethyl 2-(N-((rel-(1S,2S)-3-(((tert-Butyldimethylsilyl)oxy)-
methylene)-2-(3-hydroxypropyl)cycloheptyl)methyl)form-
amido)acetate (82). A mixture of 81 (89 mg, 0.17 mmol) and
Pd(OH)2/C (20%, 12 mg, 10 mol %) in MeOH (5.0 mL) was stirred
under a hydrogen atmosphere for 2.5 h. The mixture was filtered on
Celite and concentrated under reduced pressure. The usual
purification (40 to 100% EtOAc in hexanes) afforded a mixture of
rotamers of 82 (52 mg, 70%) as a colorless oil: 1H NMR (400 MHz,
C6D6) δ (ppm) 8.09 (s) and 7.78 (s) (1H), 6.30 (s, 1H), 3.92 (q, J =
7.0 Hz), 3.89−3.78 (m), 3.36 (d, J = 17.5 Hz), and 3.26 (d, J = 17.5
Hz) (4H), 3.73−3.61 (m) and 3.59−3.44 (m) (2H), 3.02 (dd, J =
14.5, 8.5 Hz), 2.92−2.81 (m), and 2.74 (dd, J = 14.5, 7.0 Hz) (2H),
2.26 (bs) and 2.18−2.05 (m) (2H), 1.85−1.49 (m, 5H), 1.47−1.11
(m, 6H), 1.02−0.86 (m), 0.96 (s), and 0.92 (t, J = 7.0 Hz) (14H), 0.09
(s, 6H); 13C NMR (100 MHz, C6D6) δ (ppm) 169.5 (s), 168.9 (s),
164.4 (d), 163.9 (d), 136.4 (d), 136.2 (d), 123.9 (s), 123.3 (s), 61.5
(t), 61.0 (t), 60.9 (t), 60.6 (t), 51.7 (t), 48.2 (t), 47.0 (t), 44.0 (t), 43.0
(d), 42.9 (d), 42.1 (d), 41.7 (d), 30.7 (t), 30.6 (t), 28.8 (t), 28.3 (t),
26.9 (t), 26.6 (t), 25.6 (t), 25.6 (t), 25.2 (q), 24.7 (t), 24.5 (t), 21.8
(t), 21.3 (t), 17.7 (s), 13.3 (q), 13.3 (q), −6.0 (q), −6.1 (q); IR (film)
ν (cm−1) 3592−3188, 2930, 2858, 1751, 1675, 1442, 1401, 1253,
1198; MS (ESI) m/z (rel %): 464 [MNa+] (100); HRMS (ESI) calcd
for C23H43NO5SiNa [MNa
+] 464.2830, found 464.2809.
(2Z)-Methyl 5-(rel-(1S,7S)-2-(((tert-Butyldimethylsilyl)oxy)-
methylene)-7-((N-(2-ethoxy-2-oxoethyl)formamido)methyl)-
cycloheptyl)pent-2-enoate (83). Oxalyl chloride (19 μL, 0.22
mmol) was added to a solution of DMSO (27 μL, 0.40 mmol) in
DCM (1.0 mL) at −78 °C. After 10 min at −78 °C, a solution of 82
(89 mg, 0.20 mmol) in DCM (3.0 mL) was added, and the mixture
was stirred 45 min at −78 °C. Et3N (141 μL, 1.01 mmol) was added,
and the reaction mixture was allowed to warm up to rt over 2 h.
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Saturated aqueous NaHCO3 was added; then the usual workup
(DCM) afforded the corresponding aldehyde (90 mg of crude
material). A solution of KHMDS (0.5 M in toluene, 0.40 mL, 0.20
mmol) was added to a solution of methyl bis(2,2,2-trifluoroethyl)-
phosphonoacetate (67 mg, 0.20 mmol) and 18-crown-6 ether (133
mg, 0.505 mmol) in THF (2.0 mL) at −78 °C. After 30 min at −78
°C, a solution of crude aldehyde (90 mg of crude material) in THF
(2.0 mL) was added and the reaction mixture was allowed to warm up
to rt over 2 h. Saturated aqueous NaHCO3 was added. The usual
workup (DCM) and purification (5 to 15% acetone in toluene)
afforded a mixture of rotamers of 83 (65 mg, 65% over 2 steps) as a
pale yellow oil: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.09 (s, 1H),
6.26−6.18 (m, 1H), 6.09 (s) and 6.06 (s) (1H), 5.77 (d, J = 11.5 Hz)
and 5.74 (d, J = 11.5 Hz) (1H), 4.21 (q, J = 7.0 Hz) and 4.19 (q, J =
7.0 Hz) (2H), 4.05 (d, J = 17.5 Hz), 3.98 (d, J = 17.5 Hz), 3.96 (d, J =
17.5 Hz), and 3.89 (d, J = 17.5 Hz) (2H), 3.69 (s) and 3.68 (s) (3H),
3.35 (dd, J = 14.0, 7.5 Hz), 3.26 (dd, J = 14.5, 7.5 Hz), and 3.15 (dd, J
= 14.5, 8.0 Hz) (2H), 2.60 (ddd, J = 16.5, 9.0, 5.5 Hz, 1H), 2.49 (q, J =
7.5 Hz, 2H), 2.15−2.02 (m) and 1.99−1.93 (m) (2H), 1.74−1.45 (m,
6H), 1.42−1.21 (m), 1.28 (t, J = 7.0 Hz), and 1.26 (t, J = 7.0 Hz)
(6H), 0.91 (s, 9H), 0.11 (s), 0.11 (s), and 0.10 (s) (6H); 13C NMR
(100 MHz, C6D6) δ (ppm) 169.6 (s), 168.9 (s), 166.7 (s), 166.6 (s),
163.6 (d), 163.3 (d), 151.3 (d), 150.4 (d), 136.5 (d), 136.3 (d), 123.4
(s), 122.8 (s), 120.0 (d), 119.5 (d), 60.8 (t), 60.6 (t), 51.5 (t), 50.2
(q), 50.0 (q), 48.1 (t), 46.7 (t), 44.0 (t), 43.6 (d), 43.1 (d), 42.6 (d),
42.5 (d), 28.7 (t), 28.2 (t), 27.5 (t), 27.2 (t), 26.8 (t), 26.4 (t), 26.0
(t), 25.6 (t), 25.3 (q), 25.2 (q), 24.8 (t), 17.7 (s), 13.3 (q), −6.0 (q),
−6.1 (q); IR (film) ν (cm−1) 3024, 2950, 2929, 2857, 1752, 1723,
1682, 1646, 1437, 1254, 1197, 1167, 837; MS (ESI) m/z (rel %): 518
[MNa+] (100); HRMS (ESI) calcd for C26H45NO6SiNa [MNa
+]
518.2908, found 518.2910.
Oxazolium Ion 86. Tf2O (4.3 μL, 26 μmol) was added to a
solution of 83 (11.5 mg, 23.2 μmol) and DTBMP (5.2 mg, 26 μmol)
in CDCl3 (0.6 mL) at rt. After 5 min,
1H NMR analysis showed the
formation of oxazolium ion 86: 1H NMR (300 MHz, CDCl3)
characteristic signals δ (ppm) 9.60 (s, 1H), 7.26 (d, 1H, J = 2.0 Hz),
6.33 (dt, J = 11.5, 8.0 Hz, 1H), 6.04 (s, 1H), 5.78 (d, J = 11.5 Hz, 1H),
4.42 (qd, J = 7.0, 2.0 Hz, 2H), 4.25 (d, J = 7.5 Hz, 2H), 3.68 (s, 3H),
2.70−2.48 (m, 2H), 2.39−2.27 (m, 1H), 2.13−2.01 (m, 2H), 1.98−
1.90 (m, 1H), 1.73−1.22 (m, 8H), 1.49 (t, J = 7.0 Hz, 3H), 0.89 (s,
9H), 0.10 (s), and 0.09 (s) (6H).
N-(rel-(2S,3S)-2-Allyl-3-(2-(allyloxy)vinyl)-6-(benzyloxy)-
hexyl)-N-(cyanomethyl)formamide (87). NH3 gas was condensed
(60 mL) in a solution of 75 (1.52 g, 3.86 mmol) in THF (15 mL) in a
sealed tube at −78 °C. The tube was sealed, and the solution was
stirred for 72 h at rt and then cooled at −78 °C to decrease pressure.
The sealed tube was opened, and the mixture was allowed to warm up
to rt. After complete NH3 evaporation, saturated aqueous NaHCO3
was added and THF was removed under reduced pressure. Water was
added; then the usual workup (EtOAc) afforded a mixture of E/Z
isomers and rotamers of the corresponding primary amine (1.27 g,
100%) as a colorless oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 7.34−
7.23 (m, 5H), 6.14 (d, J = 12.5 Hz) and 6.04 (d, J = 6.5 Hz) (1H),
5.99−5.69 (m, 2H), 5.34−5.17 (m, 2H), 5.08−4.98 (m, 2H), 4.53 (dd,
J = 12.5, 10.0 Hz) and 4.11 (dd, J = 10.5, 6.5 Hz) (1H), 4.49 (s, 2H),
4.22−4.17 (m, 2H), 3.46 (t, J = 6.0 Hz) and 3.44 (t, J = 6.0 Hz) (2H),
2.79−2.48 (m, 2H), 2.19−2.04 (m, 2H), 1.97−1.89 (m) and 1.71−
1.20 (m) (6H). BrCH2CN (270 μL, 4.05 mmol) was added to a
solution of primary amine (1.27 g, 3.86 mmol) and i-Pr2NEt (0.71 mL,
4.1 mmol) in THF (70 mL). The solution was stirred for 18 h at rt.
Water was added, and THF was removed under reduced pressure.
Saturated aqueous NaHCO3 was added; then the usual workup
(EtOAc) afforded a mixture of E/Z isomers and rotamers of the
secondary amine (1.46 g) as a yellow oil: 1H NMR (300 MHz,
CDCl3) δ (ppm) 7.38−7.23 (m, 5H), 6.16 (d, J = 12.5 Hz) and 6.07
(d, J = 6.5 Hz) (1H), 6.00−5.67 (m, 2H), 5.35−5.19 (m, 2H), 5.07−
4.99 (m, 2H), 4.53 (dd, J = 12.5, 10.0 Hz) and 4.12 (dd, J = 10.5, 6.5
Hz) (1H), 4.49 (s, 2H), 4.23 (d, J = 5.5 Hz) and 4.20 (d, J = 5.5 Hz)
(2H), 3.60−3.41 (m, 4H), 2.78−2.49 (m, 2H), 2.23−2.09 (m, 2H),
2.00−1.90 (m) and 1.73−1.43 (m) (5H), 1.38−1.19 (m, 2H). A
solution of secondary amine (1.42 g, 3.86 mmol) in THF (84 mL) was
treated with N-formylbenzotriazole (738 mg, 5.02 mmol). The mixture
was stirred for 20 h at rt; then aqueous NaOH (2 N) was added. The
solution was stirred for 15 min at rt; then water was added and THF
was removed under reduced pressure. The usual workup (DCM) and
purification (0 to 40% EtOAc in hexanes) afforded a mixture of E/Z
isomers and rotamers of 87 (1.02 g, 67% over 3 steps) as a colorless
oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 8.11 (s) and 8.00 (s) (1H),
7.38−7.26 (m, 5H), 6.19 (d, J = 12.5 Hz) and 6.08 (d, J = 6.5 Hz)
(1H), 6.00−5.84 (m, 1H), 5.75−5.60 (m, 1H), 5.36−5.21 (m, 2H),
5.11−5.03 (m, 2H), 4.53−4.46 (m, 1H), 4.49 (s, 2H), 4.37−4.04 (m,
4H), 3.47−3.13 (m, 2H), 3.45 (t, J = 6.0 Hz, 2H), 2.64−2.55 (m), and
2.17−1.95 (m) (3H), 1.80−1.65 (m, 2H), 1.63−1.44 (m, 2H), 1.40−
1.24 (m, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 162.6 (d),
162.5 (d), 162.4 (d), 147.5 (d), 147.2 (d), 146.1 (d), 138.3 (s), 138.3
(s), 136.2 (d), 136.0 (d), 135.2 (d), 135.1 (d), 133.5 (d), 133.1 (d),
128.1 (d), 127.4 (d), 127.3 (d), 117.5 (t), 117.3 (t), 117.2 (t), 116.8
(t), 114.5 (s), 107.3 (d), 103.8 (d), 72.6 (t), 72.5 (t), 70.0 (t), 69.6 (t),
48.7 (t), 48.5 (t), 43.7 (t), 43.2 (t), 39.9 (d), 39.6 (d), 38.8 (d), 38.2
(d), 35.8 (t), 35.4 (t), 35.3 (t), 34.1 (d), 33.8 (d), 33.6 (t), 33.3 (t),
33.0 (t), 32.8 (t), 30.2 (t), 29.8 (t), 28.8 (t), 27.8 (t), 27.6 (t), 27.5 (t),
27.3 (t); IR (film) ν (cm−1) 3077, 3032, 2937, 2861, 1681, 1428, 1163,
1096, 920; MS (EI) m/z (rel %) 355 [M+ − C3H5] (2), 311 (10), 247
(19), 163 (62), 91 (100); HRMS (EI) calcd for C24H32N2O3 [M
+]
396.2413, found 396.2417.
N-(rel-(2S,3S)-2-Allyl-3-(3-(benzyloxy)propyl)-4-formylhept-
6-enyl)-N-(cyanomethyl)formamide (88). A solution of 87 (1.40
g, 3.53 mmol) in toluene (75 mL) was heated at 150 °C in a sealed
tube for 120 h. The solution was concentrated under reduced pressure.
The usual purification using silica gel saturated with Et3N (30 to 40%
EtOAc in hexanes) afforded an inseparable mixture of diastereomers
and rotamers of 88 (1.15 g, 82%) as a colorless oil: 1H NMR (300
MHz, CDCl3) δ (ppm) 9.66 (d, J = 2.0 Hz) and 9.63 (d, J = 2.5 Hz)
(1H), 8.08 (s), 8.07 (s), 7.97 (s), and 7.96 (s) (1H), 7.36−7.26 (m,
5H), 5.77−5.60 (m, 2H), 5.11−5.03 (m, 4H), 4.48 (s) and 4.47 (s)
(2H), 4.28−4.01 (m, 2H), 3.49−3.42 (m, 2H), 3.26 (t, J = 7.0 Hz,
2H), 2.52−2.41 (m, 2H), 2.35−2.05 (m, 2H), 1.99−1.80 (m, 3H),
1.70−1.41 (m, 4H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 205.0
(d), 204.8 (d), 204.4 (d), 204.0 (d), 162.5 (d), 138.3 (s), 138.1 (s),
135.8 (d), 135.1 (d), 134.7 (d), 128.3 (d), 127.6 (d), 127.4 (d), 117.9
(t), 117.7 (t), 117.5 (t), 117.4 (t), 117.2 (t), 114.5 (s), 72.9 (t), 72.7
(t), 70.0 (t), 70.0 (t), 69.7 (t), 69.4 (t), 52.4 (d), 52.3 (d), 52.0 (d),
49.2 (t), 49.1 (t), 44.4 (t), 44.2 (t), 37.8 (d), 37.4 (d), 37.0 (d), 36.7
(d), 36.6 (d), 36.3 (d), 35.8 (t), 33.1 (t), 32.9 (t), 32.8 (t), 32.7 (t),
31.7 (t), 31.2 (t), 31.0 (t), 30.1 (t), 28.7 (t), 28.4 (t), 28.3 (t), 23.9 (t),
23.8 (t), 23.6 (t), 23.5 (t); IR (film) ν (cm−1) 3073, 2936, 2863, 1719,
1681, 1430, 1101, 918; MS (EI) m/z (rel %) 396 [M+] (2), 367 [M+ −
CHO] (7), 328 (15), 277 (18), 91 (100); HRMS (EI) calcd for
C24H32N2O3 [M
+] 396.2413, found 396.2401.
N-((rel-(1S,7S)-7-(3-(Benzyloxy)propyl)-6-formylcyclohept-3-
en-1-yl)methyl)-N-(cyanomethyl)formamide (89). Second-gener-
ation Grubbs’ catalyst (41 mg, 5 mol %) was added to a solution of 88
(381 mg, 0.961 mmol) in DCM (160 mL). The solution was stirred
for 18 h at rt and then concentrated under reduced pressure. The usual
purification (20 to 50% EtOAc in hexanes) afforded an inseparable
mixture of diastereomers and rotamers of 89 (303 mg, 86%) as a
brown oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 9.71 (s), 9.65 (s),
and 9.63 (s) (1H), 8.17 (s), 8.09 (s), 8.01 (s), and 8.00 (s) (1H),
7.38−7.26 (m, 5H), 5.83−5.61 (m, 2H), 4.57 (d, J = 17.5 Hz), 4.19 (d,
J = 17.5 Hz), 4.08 (d, J = 17.5 Hz), and 4.60−4.06 (m) (2H), 4.49 (s)
and 4.47 (s) (2H), 3.78 (dd, J = 14.0, 10.0 Hz), 3.49−3.34 (m), 3.32−
3.20 (m), and 3.07 (dd, J = 14.0, 6.0 Hz) (4H), 2.62−2.50 (m, 2H),
2.43−2.15 (m), 2.10−2.00 (m), 1.83 (dd, J = 14.0, 7.0 Hz), and 1.77−
1.32 (m) (9H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 205.6 (d),
204.5 (d), 203.8 (d), 203.4 (d), 162.6 (d), 162.4 (d), 162.2 (d), 138.2
(s), 131.3 (d), 130.7 (d), 129.1 (d), 128.3 (d), 128.0 (d), 127.6 (d),
127.5 (d), 114.7 (s), 114.6 (s), 72.9 (t), 72.9 (t), 72.7 (t), 70.3 (t),
70.2 (t), 69.5 (t), 56.5 (d), 56.0 (d), 51.7 (t), 51.3 (d), 50.0 (t), 47.4
(t), 44.8 (t), 43.7 (d), 41.5 (d), 41.1 (d), 38.5 (d), 38.2 (d), 36.3 (d),
36.1 (d), 35.3 (t), 33.7 (d), 33.5 (d), 30.5 (t), 29.6 (t), 28.8 (t), 28.4
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(t), 28.2 (t), 27.6 (t), 27.1 (t), 27.1 (t), 24.1 (t), 23.9 (t), 23.7 (t), 22.4
(t), 22.1 (t), 21.2 (t), 21.0 (t); IR (film) ν (cm−1) 3028, 2940, 2868,
1719, 1678, 1435, 1180, 1097; MS (EI) m/z (rel %) 368 [M+] (5),
340 (3), 277 (8), 91 (100); HRMS (EI) calcd for C22H28N2O3 [M
+]
368.2100, found 368.2108.
N-((rel-(1S,7S,E)-7-(3-(Benzyloxy)propyl)-6-((tert-butyl-
dimethylsilyloxy)methylene)cyclohept-3-enyl)methyl)-N-
(cyanomethyl)formamide (E-90) and N-((rel-(1S,7S,Z)-7-(3-
(Benzyloxy)propyl)-6-((tert-butyldimethylsilyloxy)methylene)-
cyclohept-3-enyl)methyl)-N-(cyanomethyl)formamide (Z-90).
Following the procedure used to prepare 40, a solution of 89 (304
mg, 0.825 mmol) in DCM (16.5 mL) was treated with TBDMSOTf
(284 μL, 1.24 mmol) and i-Pr2NEt (287 μL, 1.65 mmol) for 18 h at rt
to afford, after the usual purification using silica gel saturated with
Et3N (0 to 40% EtOAc in hexanes), E-90 (187 mg) and Z-90
54 (63
mg) (63% global yield) as colorless oils. E-90 and Z-90 both exist as a
mixture of rotamers and were separated at this stage. However, due to
the instability of the products, full characterization was not possible
and both isomers were carried through the sequence separately. Only
the sequence with the major isomer E-90 is reported thereafter: E-90
(major) 1H NMR (300 MHz, CDCl3) δ (ppm) 8.14 (s) and 8.00 (s)
(1H), 7.38−7.28 (m, 5H), 6.05 (s, 1H), 5.82−5.75 (m, 1H), 5.57−
5.52 (m, 1H), 4.49 (s, 2H), 4.32 (d, J = 17.5 Hz, 1H), 4.14 (d, J = 17.5
Hz, 1H), 3.46 (t, J = 5.5 Hz, 2H), 3.33−3.19 (m, 2H), 3.10 (dd, J =
17.5, 6.5 Hz, 1H), 2.70−2.64 (m, 1H), 2.12−1.92 (m, 4H), 1.71−1.56
(m, 2H), 1.49−1.34 (m, 2H), 0.91 (s, 9H), 0.11 (s, 6H). Z-90 (minor)
1H NMR (300 MHz, CDCl3) δ (ppm) 8.14 (s) and 8.02 (s) (1H),
7.38−7,28 (m, 5H), 6.13 (s) and 6.10 (s) (1H), 5.71−5.65 (m, 1H),
5.57−5.50 (m, 1H), 4.59 (d, J = 17.5 Hz, 1H), 4.49 (s, 2H), 4.19 (d, J
= 2.0 Hz) and 4.09 (d, J = 17.5 Hz) (1H), 3.45 (t, J = 6.0 Hz, 2H),
3.38−3.23 (m, 2H), 2.99−2.95 (m, 1H), 2.79−2.73 (m, 1H), 2.47 (dd,
J = 18.0, 7.0 Hz, 1H), 2.09−1.88 (m, 3H), 1.68−1.27 (m, 4H), 0.90 (s,
9H), 0.12 (s) and 0.11 (s) (6H).
N-((rel-(1S,7S,E)-6-((tert-Butyldimethylsilyloxy)methylene)-7-
(3-hydroxypropyl)cyclohept-3-enyl)methyl)-N-(cyanomethyl)-
formamide (E-91). A solution of Me2BBr (1.0 M in DCM, 3.87 mL,
3.87 mmol) was added to a solution of E-90 (187 mg, 0.387 mmol)
and DTBMP (795 mg, 3.87 mmol) in DCM (8.0 mL) at −25 °C. The
solution was stirred for 2 h at −25 °C; then saturated aqueous
NaHCO3 (2.0 mL) was added at −25 °C. The mixture was stirred for
15 min at rt, and saturated aqueous NaCl was added. The usual
workup (DCM) and purification using silica gel saturated with Et3N
(10 to 100% EtOAc in hexanes) afforded a mixture of rotamers of E-
91 (110 mg, 72%) as a yellow oil: 1H NMR (400 MHz, CDCl3) δ
(ppm) 8.19 (s) and 8.03 (s) (1H), 6.07 (s) and 6.04 (s) (1H), 5.80−
5.74 (m, 1H), 5.56−5.52 (m, 1H), 4.31 (d, J = 17.5 Hz), 4.17 (d, J =
17.5 Hz), and 4.17 (d, J = 3.3 Hz) (2H), 3.63−3.57 (m, 2H), 3.33 (dd,
J = 14.5, 7.0 Hz, 1H), 3.24 (dd, J = 14.5, 8.0 Hz, 1H), 3.11 (dd, J =
17.5, 6.5 Hz, 1H), 2.65−2.63 (m) and 2.54−2.49 (m) (1H), 2.12−
2.05 (m, 2H), 2.00−1.89 (m) and 1.78 (bs) (3H), 1.61−1.54 (m, 2H),
1.43−1.36 (m, 2H), 0.90 (s, 9H), 0.11 (s) and 0.10 (s) (6H); 13C
NMR (100 MHz, CDCl3) δ (ppm) 162.8 (d), 162.6 (d), 135.0 (d),
134.7 (d), 130.1 (d), 129.3 (d), 126.9 (d), 126.4 (d), 121.0 (s), 119.6
(s), 114.5 (s), 62.1 (t), 61.7 (t), 50.2 (t), 46.3 (t), 43.5 (d), 42.3 (d),
40.3 (d), 39.6 (d), 36.0 (t), 30.3 (t), 30.2 (t), 30.0 (t), 29.0 (t), 28.6
(t), 25.6 (q), 25.1 (t), 24.5 (t), 21.8 (t), 20.2 (t), 18.2 (s), −5.3 (q),
−5.4 (q); IR (film) ν (cm−1) 3611−3132, 2956, 2930, 2889, 2859,
1673, 1465, 1433, 1402, 1253, 1179; MS (EI) m/z (rel %) 392 [M+]
(10), 335 [M+ − C4H9] (17), 249 (34), 74 (100); HRMS (EI) calcd
for C21H36N2O3Si [M
+] 392.2495, found 392.2503.
(Z)-Methyl 5-(rel-(1S,7S,E)-2-((tert-Butyldimethylsilyloxy)-
methylene)-7-((N-(cyanomethyl)formamido)methyl)cyclohept-
4-enyl)pent-2-enoate (E-92). Following the procedure used to
prepare 83, a solution of E-91 (350 mg, 0.891 mmol) in DCM (6.0
mL) was added to a solution of oxalyl chloride (101 μL, 1.16 mmol)
and DMSO (127 μL, 1.78 mmol) in DCM (12 mL), and the mixture
was then treated with Et3N (621 μL, 4.46 mmol) to afford the
corresponding aldehyde (350 mg of crude material). A solution of
crude aldehyde in THF (6.0 mL) was then added to a solution of
KHMDS (0.5 M in toluene, 1.78 mL, 0.891 mmol), methyl bis(2,2,2-
trifluoroethyl)phosphonoacetate (298 mg, 0.891 mmol), and 18-
crown-6 ether (588 mg, 2.23 mmol) in THF (12 mL) to afford, after
the usual workup (Et2O) and purification (5 to 15% acetone in
toluene), a mixture of rotamers of E-92 (188 mg, 47% over 2 steps) as
a colorless oil: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.18 (s) and
8.04 (s) (1H), 6.26 (dt, J = 11.5, 8.0 Hz, 1H), 6.06 (s, 1H), 5.82−5.79
(m, 2H), 5.56−5.51 (m, 1H), 4.38 (d, J = 17.5 Hz, 1H), 4.12 (d, J =
17.5 Hz, 1H), 3.70 (s, 3H), 3.34−3.23 (m, 2H), 3.02 (dd, J = 17.0, 6.0
Hz, 1H), 2.84−2.79 (m, 1H), 2.66−2.60 (m, 1H), 2.54−2.48 (m, 1H),
2.20−2.16 (m, 1H), 2.09−2.02 (m, 3H), 1.73−1.65 (m, 1H), 1.49−
1.40 (m, 1H), 0.91 (s, 9H), 0.12 (s, 6H); 13C NMR (100 MHz,
CDCl3) major rotamer δ (ppm) 166.6 (s), 162.7 (d), 149.5 (d), 135.1
(d), 130.4 (d), 126.3 (d), 120.0 (d), 119.2 (s), 114.6 (s), 51.1 (q),
49.5 (t), 44.5 (d), 38.6 (d), 30.3 (t), 28.8 (t), 27.1 (t), 26.2 (t), 25.8
(t), 25.6 (q), 18.3 (s), −5.3 (q), −5.3 (q); IR (film) ν (cm−1) 2952,
2928, 2857, 1720, 1680, 1462, 1437, 1406, 1254, 1198, 1177, 1154;
MS (ESI) m/z (rel %) 469 [MNa+] (100), 353 (12), 130 (7); HRMS
(ESI) calcd for C24H38N2NaO4Si [MNa
+] 469.2498, found 469.2488.
rel-(4R,5S)-4-(2-(Allyloxy)vinyl)-5-(bromomethyl)oct-7-en-1-
ol (93). TMSI (11.2 mL, 78.5 mmol) was added to a solution of 75
(3.94 g, 8.73 mmol) and i-Pr2NEt (18.2 mL, 105 mmol) in DCM (85
mL) at 0 °C. The solution was stirred for 18 h at rt; then water was
added. The layers were separated, and the aqueous phase was extracted
with EtOAc. Combined organic phases were washed twice with
aqueous HCl (0.2 N) and with saturated aqueous NaCl, then dried
over anhydrous Na2SO4, filtered, and concentrated under reduced
pressure. The crude material was dissolved in MeOH (85 mL), and
K2CO3 (2.41 g, 17.5 mmol) was added at 0 °C. The solution was
stirred for 15 min at 0 °C; then water was added and MeOH was
removed under reduced pressure. The usual workup (EtOAc, washed
with brine) and purification using silica gel saturated with Et3N (0 to
30% EtOAc in hexanes) afforded a mixture of E/Z isomers of 93 (2.19
g, 91%) as a yellow pale oil: 1H NMR (300 MHz, CDCl3) δ (ppm)
6.24 (d, J = 12.5 Hz) and 6.08 (d, J = 6.5 Hz) (1H), 6.01−5.85 (m,
1H), 5.83−5.64 (m, 1H), 5.38−5.14 (m, 2H), 5.11 (d, J = 15.5 Hz)
and 5.07 (d, J = 9.5 Hz) (2H), 4.47 (dd, J = 12.5, 10.5 Hz) and 4.09
(dd, J = 10.0, 6.5 Hz) (1H), 4.28−4.16 (m, 2H), 3.70−3.58 (m, 2H),
3.54 (dd, J = 10.0, 4.0 Hz) and 3.43−3.32 (m) (2H), 2.79−2.66 (m)
and 2.09−1.95 (m) (1H), 2.35−2.11 (m, 2H), 1.76−1.18 (m, 6H);
13C NMR (75.5 MHz, CDCl3) δ (ppm) major isomer: 147.0 (d),
135.9 (d), 133.2 (d), 117.3 (t), 117.0 (t), 105.0 (d), 69.9 (t), 62.3 (t),
43.9 (d), 39.7 (d), 37.3 (t), 33.9 (t), 30.4 (t), 28.5 (t); minor isomer:
145.9 (d), 135.7 (d), 133.7 (d), 117.3 (t), 117.0 (t), 107.6 (d), 72.4
(t), 62.5 (t), 44.4 (d), 36.9 (t), 35.5 (d), 33.9 (t), 30.2 (t), 28.4 (t); IR
(film) ν (cm−1) 3616-3172, 3077, 3017, 2921, 2867, 1664, 1644, 1455,
1425, 1161, 921; MS (ESI) m/z (rel %) 327 [MNa+] (92, 81Br), 325
[MNa+] (100, 79Br); HRMS (ESI) calcd for C14H23
79BrO2Na [MNa
+]
325.0774, found 325.0779.
N-(rel-(2S,3S)-2-Allyl-3-(2-(allyloxy)vinyl)-6-hydroxyhexyl)-N-
(cyanomethyl)formamide (94). Following the procedure used to
prepare 87, a solution of 93 (773 mg, 2.55 mmol) in THF (6.0 mL)
was treated with NH3 gas (25 mL) for 96 h at rt to afford the
corresponding primary amine (608 mg, crude product). A solution of
the crude primary amine in THF (43 mL) was then treated with i-
Pr2NEt (465 μL, 2.67 mmol) and BrCH2CN (178 μL, 2.67 mmol) for
18 h at rt to afforded the corresponding secondary amine (707 mg,
crude product) as a pale yellow oil. A solution of the crude secondary
amine in THF (42 mL) was then treated with N-formylbenzotriazole
(448 mg, 3.05 mmol) for 18 h at rt to afford, after the usual
purification using silica gel saturated with Et3N (40 to 100% EtOAc in
hexanes), an inseparable mixture of E/Z isomers of 94 (504 mg, 65%
over 3 steps) each in a 8:1 rotamer ratio, as a colorless oil: 1H NMR
(400 MHz, CDCl3) δ (ppm) 8.15 (s) and 8.02 (s) (1H), 6.21 (d, J =
12.5 Hz), 6.09 (d, J = 6.0 Hz), and 6.03 (d, J = 6.0 Hz) (1H), 5.98−
5.83 (m, 1H), 5.81−5.58 (m, 1H), 5.37−5.18 (m, 2H), 5.13−4.96 (m,
2H), 4.74−4.69 (m), 4.62−4.57 (m), 4.51 (dd, J = 12.5, 10.5 Hz), 4.36
(d, J = 17.5 Hz), 4.30−4.18 (m), 4.17−4.12 (m), 4.09 (d, J = 17.5 Hz),
and 3.98−3.90 (m) (5H), 3.68−3.53 (m, 2H), 3.43 (dd, J = 14.5, 5.0
Hz), 3.37 (d, J = 6.0 Hz), 3.28 (dd, J = 14.5, 8.5 Hz), and 3.18 (dd, J =
14.5, 9.5 Hz) (2H), 2.73−2.49 (m) and 2.22−1.90 (m) (3H), 1.86−
1.13 (m, 6H); 13C NMR (100 MHz, CDCl3) only the major rotamer
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of E and Z isomers reported δ (ppm) 163.5 (d), 163.4 (d), 148.2 (d),
146.8 (d), 135.8 (d), 135.6 (d), 133.9 (d), 133.6 (d), 118.2 (t), 118.1
(t), 118.0 (t), 118.0 (t), 114.9 (s), 114.8 (s), 107.8 (d), 104.2 (d), 72.8
(t), 70.3 (t), 62.3 (t), 62.2 (t), 48.7 (t), 48.5 (t), 40.0 (d), 39.8 (d),
38.2 (d), 33.7 (d), 33.0 (t), 32.8 (t), 30.2 (t), 30.1 (t), 30.0 (t), 29.7
(t), 28.2 (t), 27.2 (t); IR (film) ν (cm−1) 3647−3156, 3080, 2933,
2871, 1672, 1431, 1285; MS (ESI) m/z (rel %) 345 [MK+] (2), 329
[MNa+] (100), 290 (18); HRMS (ESI) calcd for C17H26N2O3Na
[MNa+] 329.1836, found 329.1836.
(2Z)-rel-(6S,7S)-Methyl 6-(2-(allyloxy)vinyl)-7-((N-(cyano-
methyl)formamido)methyl)deca-2,9-dienoate (95). Following
the procedure used to prepare 83, a solution 94 (197 mg, 0.643
mmol) in DCM (3.0 mL) was added to a solution of oxalyl chloride
(62 μL, 0.71 mmol) and DMSO (92 μL, 1.3 mmol) in DCM (10 mL),
and the mixture was then treated with Et3N (450 μL, 3.22 mmol) to
afford the corresponding aldehyde (196 mg of crude material). A
solution of crude aldehyde in THF (3.0 mL) was then added to a
solution of KHMDS (0.5 M in toluene, 1.42 mL, 0.707 mmol), methyl
bis(2,2,2-trifluoroethyl)phosphonoacetate (215 mg, 0.643 mmol), and
18-crown-6 ether (425 mg, 1.61 mmol) in THF (10 mL) to afford,
after the usual workup (Et2O) and purification using silica gel
saturated with Et3N (20 to 60% EtOAc in hexanes), an inseparable
mixture of E/Z isomers and rotamers of 95 (176 mg, 76% over 2
steps) as a pale yellow oil: 1H NMR (400 MHz, CDCl3) δ (ppm) 8.12
(s) and 7.99 (s) (1H), 6.23−6.12 (m), 6.18 (d, J = 12.5 Hz), and 6.08
(d, J = 6.5 Hz) (2H), 5.95−5.81 (m, 1H), 5.76 (d, J = 11.5 Hz) and
5.73−5.55 (m) (2H), 5.29 (dd, J = 17.5, 1.5 Hz), 5.21 (dd, J = 10.5,
1.0 Hz), and 5.09−4.96 (m) (4H), 4.57 (d, J = 6.5 Hz) and 4.49 (dd, J
= 12.5, 10.0 Hz) (1H), 4.37 (d, J = 17.5 Hz), 4.26 (s), and 4.13 (d, J =
17.5 Hz) (2H), 4.22−4.16 (m, 2H), 3.66 (s, 3H), 3.52−3.21 (m), 3.41
(dd, J = 14.5, 4.5 Hz), and 3.14 (dd, J = 14.5, 10.0 Hz) (2H), 2.75−
2.46 (m, 2H), 2.12−1.92 (m, 3H), 1.85−1.73 (m, 1H), 1.62−1.52 (m,
1H), 1.47−1.30 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm) E-
isomer (major rotamer): 166.5 (s), 162.7 (d), 149.5 (d), 147.8 (d),
135.1 (d), 133.1 (d), 119.7 (d), 117.8 (t), 117.5 (t), 114.6 (s), 103.3
(d), 70.2 (t), 51.0 (q), 48.6 (t), 39.1 (d), 38.3 (d), 33.3 (t), 31.8 (t),
30.3 (t), 26.8 (t); Z-isomer (major rotamer) and E-isomer (minor
rotamer): 166.6 (s), 162.8 (d), 162.4 (d), 150.0 (d), 149.9 (d), 147.5
(d), 146.4 (d), 136.0 (d), 135.2 (d), 133.5 (d), 133.2 (d), 119.5 (d),
119.4 (d), 117.6 (t), 117.4 (t), 117.0 (t), 114.8(s), 106.8 (d), 103.4
(d), 72.7 (t), 69.9 (t), 50.9 (q), 48.6 (t), 43.7 (t), 39.4 (d), 38.7 (d),
36.0 (t), 34.2 (d), 33.8 (t), 33.1 (t), 31.7 (t), 31.0 (t), 30.0 (t), 26.9
(t), 26.8 (t); IR (film) ν (cm−1) 3083, 2982, 2927, 2876, 1719, 1680,
1644, 1437, 1407, 1203, 1175; MS (ESI) m/z (rel %) 399 [MK+] (9),
383 [MNa+] (100); HRMS (ESI) calcd for C20H28N2O4Na [MNa
+]
383.1941, found 383.1941.
(Z)-Methyl 5-(rel-(1S,2S)-2-((N-(Cyanomethyl)formamido)-
methyl)-7-formylcyclohept-4-en-1-yl)pent-2-enoate (96). A
solution of 95 (359 mg, 1.00 mmol) in toluene (20 mL) was heated
at 155 °C in a sealed tube for 96 h. The solution was concentrated
under reduced pressure to afford the corresponding diene (359 mg of
crude product). The crude diene (359 mg) was dissolved in DCM
(165 mL), and second-generation Grubbs’ catalyst (42 mg, 5 mol %)
was added. The solution was stirred for 3 h at rt and then concentrated
under reduced pressure. The usual purification (40 to 80% EtOAc in
hexanes) afforded an inseparable mixture of diastereomers and
rotamers of 96 (213 mg, 64%) as a brown oil: 1H NMR (400 MHz,
CDCl3) δ (ppm) 9.74 (s), 9.73 (s), 9.65 (s), and 9.64 (s) (1H), 8.22
(s), 8.16 (s), 8.15 (s), and 8.07 (s) (1H), 6.21 (dt, J = 11.5, 8.0 Hz,
1H), 5.88−5.62 (m, 3H), 4.64 (d, J = 17.5 Hz), 4.49 (d, J = 17.5 Hz),
4.41 (d, J = 18.0 Hz), 4.32 (s), 4.27 (s), 4.26 (d, J = 17.5 Hz), and 4.18
(d, J = 17.5 Hz) (2H), 3.90 (dd, J = 14.5, 10.5 Hz), 3.47 (dd, J = 14.5,
6.0 Hz), 3.43−3.25 (m), and 3.01 (dd, J = 14.5, 5.0 Hz) (2H), 3.70
(s), 3.69 (s), and 3.67 (s) (3H), 2.79−1.77 (m, 9H), 1.71−1.40 (m,
2H); 13C NMR (100 MHz, CDCl3) only the major rotamer of each
diastereomer reported δ (ppm) 205.2 (d), 204.0 (d), 167.2 (s), 167.1
(s), 163.5 (d), 163.1 (d), 149.0 (d), 148.9 (d), 131.0 (d), 129.8 (d),
129.0 (d), 128.6 (d), 121.0 (d), 120.7 (d), 115.0 (s), 114.9 (s), 55.6
(d), 51.1 (t), 51.1 (d), 51.0 (q), 50.8 (q), 49.3 (t), 40.3 (d), 39.1 (d),
36.5 (d), 33.1 (d), 30.2 (t), 29.4 (t), 28.0 (t), 27.4 (t), 27.1 (t), 25.6
(t), 25.2 (t), 24.7 (t), 24.3 (t), 24.0 (t); IR (film) ν (cm−1) 3022, 2948,
2934, 1718, 1678, 1437, 1406, 1202, 1177; MS (ESI) m/z (rel %) 371
[MK+] (29), 355 [MNa+] (100), 333 [MH+] (2); HRMS (ESI) calcd
for C18H24N2O4Na [MNa
+] 355.1628, found 355.1630.
Methyl rel-(1R,2S,3R,6S,11S,12S,15S)-4-Aza-3-cyano-11-
formyltetracyclo[9.3.1.04,15.06,12]pentadec-8-ene-2-carboxylate
(98α-CN) and Methyl rel-(1R,2S,3S,6S,11S,12S,15S)-4-Aza-3-
cyano-11-formyltetracyclo[9.3.1.04,15.06,12]pentadec-8-ene-2-
carboxylate (98β-CN). Tf2O (84 μL, 0.50 mmol) was added to a
solution of 92 (178 mg, 0.399 mmol) and DTBMP (246 mg, 1.20
mmol) in DCM (40 mL) at rt. After 15 min at rt, an additional portion
of Tf2O (84 μL, 0.50 mmol) was added and another additional portion
(35 μL, 0.21 mmol) after 10 min. Progression of the Vilsmeier−Haack
cyclization was monitored by TLC. i-Pr2NEt (0.56 mL, 3.2 mmol) was
then added at rt, and the mixture was stirred for 1 h. Saturated aqueous
NaHCO3 was added. The usual workup (EtOAc) and purification (2
to 10% MeCN in toluene) afforded two separable diastereomers 98α-
CN (54.5 mg) and 98β-CN (52.5 mg) (86% global yield) as pale
yellow oils: 98α-CN: 1H NMR (400 MHz, CDCl3) δ (ppm) 9.39 (s,
1H), 5.70−5.59 (m, 2H), 4.31 (bs, 1H), 3.75 (s, 3H), 3.41 (dd, J =
14.0, 8.5 Hz, 1H), 3.33 (dd, J = 9.0, 6.0 Hz, 1H), 3.18 (dd, J = 14.0, 5.5
Hz, 1H), 3.13 (bs, 1H), 2.81−2.74 (m, 1H), 2.55−2.47 (m, 1H),
2.35−2.19 (m, 4H), 1.72−1.45 (m, 5H); 13C NMR (75.5 MHz,
CDCl3) δ (ppm) 201.2 (d), 169.7 (s), 128.9 (d), 124.9 (d), 117.3 (s),
61.6 (d), 54.7 (d), 52.2 (q), 52.2 (d), 50.3 (s), 49.7 (t), 37.5 (d), 36.4
(t), 34.6 (d), 34.0), 32.6 (t), 28.3 (t), 19.1 (t); IR (film) ν (cm−1)
3016, 2956, 2930, 2889, 1722, 1439, 1203, 1177; MS (ESI) m/z (rel
%) 315 [MH+] (100), 288 [M+ − CN] (13), 198 (6); HRMS (ESI)
calcd for C18H23N2O3 [MH
+] 315.1709, found 315.1704. 98β-CN: 1H
NMR (400 MHz, CDCl3) δ (ppm) 9.39 (s, 1H), 5.65−5.57 (m, 2H),
4.27 (d, J = 8.0 Hz, 1H), 3.74 (s, 3H), 3.42 (bs, 1H), 3.35 (dd, J = 8.0,
6.0 Hz, 1H), 3.29 (dd, J = 14.0, 6.5 Hz, 1H), 2.94 (dd, J = 14.0, 9.0 Hz,
1H), 2.75−2.63 (m, 2H), 2.31−2.11 (m, 4H), 1.64−1.52 (m, 2H),
1.50−1.35 (m, 2H), 1.15−1.03 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ (ppm) 201.1 (d), 170.5 (s), 128.8 (d), 124.4 (d), 120.9 (s),
61.2 (d), 57.8 (d), 55.4 (d), 53.9 (t), 52.5 (q), 50.3 (s), 38.5 (d), 36.3
(t), 34.2 (d), 33.2 (d), 31.7 (t), 28.1 (t), 18.6 (t); IR (film) ν (cm−1)
3016, 2928, 2885, 1725, 1438, 1241, 1204, 1170; MS (ESI) m/z (rel
%) 315 [MH+] (100), 288 [M+ − CN] (11), 198 (5); HRMS (ESI)
calcd for C18H23N2O3 [MH
+] 315.1709, found 315.1714.
N-(rel-(2S,3S)-(6Z)-2-Allyl-3-(2-(allyloxy)vinyl)oct-6-en-1-yl)-
N-(cyanomethyl)formamide (99). Following the procedure used to
prepare 83, a solution of 94 (100 mg, 0.326 mmol) in DCM (2.0 mL)
was added to a solution of oxalyl chloride (32 μL, 0.36 mmol) and
DMSO (46 μL, 0.65 mmol) in DCM (5 mL), and the mixture was
then treated with Et3N (227 μL, 1.63 mmol) to afford the
corresponding aldehyde (107 mg of crude material). Ph3PEtBr (145
mg, 0.390 mmol) was added to a solution of t-BuOK (40 mg, 0.36
mmol) in THF (4.0 mL) at 0 °C. After 20 min at rt, a solution of
aldehyde (107 mg of crude material) in THF (2.5 mL) was added, and
the mixture was allowed to warm up to rt and stirred 18 h. Water was
added, and solvent was removed under reduced pressure. Saturated
aqueous NaHCO3 was added. The usual workup (EtOAc) and
purification using silica gel saturated with Et3N (30% EtOAc in
hexanes) afforded a mixture of E/Z isomers (for the allyl enol ether)
and rotamers of 99 (27 mg, 76% over 2 steps) as a pale yellow oil: 1H
NMR (400 MHz, CDCl3) δ (ppm) 8.13 (s) and 8.01 (s) (1H), 6.19
(d, J = 12.5 Hz), 6.18 (d, J = 12.5 Hz), 6.09 (d, J = 6.5 Hz), and 6.06
(d, J = 5.5 Hz) (1H), 5.98−5.83 (m, 1H), 5.81−5.62 (m, 1H), 5.50−
5.38 (m, 1H), 5.37−5.20 (m, 3H), 5.10−5.00 (m, 2H), 4.55 (dd, J =
12.5, 10.0 Hz), 4.51 (dd, J = 12.5, 10.0 Hz), and 4.14 (dd, J = 6.5, 3.5
Hz) (1H), 4.35 (d, J = 17.5 Hz), 4.28−4.17 (m), 4.09 (d, J = 17.5 Hz)
(4H), 3.41 (dd, J = 14.5, 5.0 Hz), 3.36 (dd, J = 14.5, 6.0 Hz), 3.28 (dd,
J = 14.5, 8.0 Hz), and 3.18 (dd, J = 14.5, 9.5 Hz) (2H), 2.62−2.53 (m)
and 2.17−1.89 (m) (5H), 1.80−1.56 (m, 4H), 1.50−1.40 (m, 1H),
1.38−1.20 (m, 1H); 13C NMR (100 MHz, CDCl3) δ (ppm) 162.7 (d),
162.7 (d), 162.3 (d), 162.2 (d), 147.8 (d), 147.5 (d), 146.3 (d), 146.0
(d), 136.5 (d), 136.1 (d), 135.4 (d), 135.2 (d), 133.7 (d), 133.6 (d),
133.3 (d), 133.2 (d), 130.3 (d), 130.0 (d), 129.9 (d), 129.6 (d), 124.6
(d), 124.4 (d), 124.2 (d), 124.0 (d), 117.9 (t), 117.7 (t), 117 0.7 (t),
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117.6 (t), 117.1 (t), 116.7 (t), 114.6 (s), 114.5 (s), 108.3 (d), 107.8
(d), 104.1 (d), 72.8 (t), 72.7 (t), 70.4 (t), 70.1 (t), 48.9 (t), 48.7 (t),
44.2 (t), 43.4 (t), 40.2 (d), 40.1 (d), 40.0 (d), 39.7 (d), 38.7 (d), 38.1
(d), 38.0 (d), 36.2 (t), 35.6 (t), 34.1 (t), 34.0 (t), 33.9 (t), 33.5 (t),
33.3 (t), 33.0 (t), 32.3 (t), 31.4 (t), 30.9 (t), 30.3 (t), 29.9 (t), 25.0 (t),
24.8 (t), 24.7 (t), 24.6 (t), 17.9 (q), 12.9 (q), 12.9 (q), 12.7 (q); IR
(film) ν (cm−1) 3077, 3017, 2932, 2867, 1679, 1425, 1405, 1161; MS
(ESI) m/z (rel %) 339 [MNa+] (100); HRMS (ESI) calcd for
C19H28N2O2Na [MNa
+] 339.2043, found 339.2049.
N-(rel-(2S,3S)-(Z)-2-Allyl-3-(1-oxopent-4-en-2-yl)oct-6-en-1-
yl)-N-(cyanomethyl)formamide (100). A solution of 99 (27 mg, 85
μmol) in toluene (3.0 mL) was heated at 155 °C in a sealed tube for
144 h. The solution was concentrated under reduced pressure. The
usual purification using silica gel saturated with Et3N (20 to 40%
EtOAc in hexanes) afforded an inseparable mixture of diastereomers
and rotamers of 100 (24 mg, 89%) as a cololess oil: 1H NMR (400
MHz, CDCl3) δ (ppm) 9.71 (d, J = 2.0 Hz), 9.78 (d, J = 2.0 Hz), and
9.67 (d, J = 2.0 Hz) (1H), 8.15 (s), 8.14 (s), 8.11 (s), and 8.02 (s)
(1H), 5.80−5.61 (m, 2H), 5.57−5.42 (m, 1H), 5.39−5.25 (m, 1H),
5.18−4.99 (m, 4H), 4.43−4.08 (m), 4.36 (d, J = 17.5 Hz), 4.32 (d, J =
16.0 Hz), 4.18 (d, J = 17.5 Hz), and 4.13 (d, J = 17.5 Hz) (2H), 3.65−
3.49 (m) and 3.36−3.19 (m) (2H), 2.60−2.40 (m, 2H), 2.38−1.79
(m, 7H), 1.68−1.32 (m, 2H), 1.59 (d, J = 6.0 Hz, 3H); 13C NMR (100
MHz, CDCl3) δ (ppm) 208.1 (d), 205.1 (d), 204.8 (d), 204.0 (d),
162.6 (d), 162.5 (d), 135.9 (d), 135.3 (d), 135.1 (d), 134.8 (d), 134.7
(d), 132.1 (d), 129.4 (d), 129.3 (d), 128.8 (d), 128.8 (d) 125.5 (d),
125.1 (d), 124.8 (d), 119.7 (t), 118.2 (t), 118.1 (t), 117.9 (t), 117.7
(t), 117.6 (t), 117.5 (t), 117.3 (t), 114.5 (s), 114.5 (s), 114.4 (s), 52.5
(d), 52.4 (d), 52.1 (d), 50.5 (t), 49.2 (t), 49.2 (t), 45.7 (d), 44.5 (t),
40.1 (d), 38.0 (d), 37.5 (d), 37.4 (d), 37.3 (d), 36.9 (d), 36.6 (d), 36.3
(d), 36.0 (t), 36.0 (t), 34.7 (t) 34.0 (t), 33.2 (t), 33.1 (t), 33.0 (t), 32.9
(t), 31.6 (t), 31.2 (t), 31.2 (t), 31.1 (t), 30.2 (t), 30.2 (t), 27.2 (t), 27.1
(t), 26.7 (t), 26.6 (t), 26.3 (t), 25.8 (t), 25.5 (t), 25.4 (t), 25.3 (t), 24.7
(t), 13.4 (q), 13.0 (q), 12.9 (q), 12.8 (q); IR (film) ν (cm−1) 3077,
3012, 2927, 2862, 1724, 1672, 1430, 1395, 1180, 916; MS (ESI) m/z
(rel %) 371 [MNa+ + MeOH] (32), 355 [MK+] (30), 339 [MNa+]
(100); HRMS (ESI) calcd for C19H28N2O2Na [MNa
+] 339.2043,
found 339.2046.
N-(Cyanomethyl)-N-((rel-(1S,7S)-6-formyl-7-((Z)-pent-3-en-1-
yl)cyclohept-3-en-1-yl)methyl)formamide (101). First-generation
Grubbs’ catalyst (5.9 mg, 5 mol %) was added to a solution of 100
(45.2 mg, 0.143 mmol) in DCM (14.5 mL). The solution was stirred
for 6 h at rt with N2 bubbling; then another portion of first-generation
Grubbs’ catalyst (5.9 mg, 5 mol %) was added. The solution was
stirred at rt for 18 h, and water was finally added. The usual workup
(DCM) and purification (0 to 40% EtOAc in hexanes) afforded an
inseparable mixture of diastereomers and rotamers of 101 (36.0 mg,
88%) as a pale yellow oil: 1H NMR (300 MHz, CDCl3) δ (ppm) 9.73
(s) and 9.65 (s) (1H), 8.22 (s), 8.17 (s), 8.06 (s), and 8.02 (s) (1H),
5.86−5.57 (m), 5.54−5.41 (m), 5.37−5.23 (m), and 5.14−4.96 (m)
(4H), 4.66−4.02 (m), 4.62 (d, J = 17.5 Hz), 4.49 (d, J = 17.5 Hz), 4.22
(d, J = 17.5 Hz), and 4.12 (d, J = 17.5 Hz) (2H), 3.49−3.05 (m, 2H),
2.66−1.72 (m, 10H), 1.67−1.13 (m) and 1.08−0.83 (m) (4H); 13C
NMR (75.5 MHz, CDCl3) only the major rotamer of each
diastereomer reported δ (ppm) 204.6, 203.3, 162.4, 162.3, 130.9,
129.2, 128.9, 128.8, 128.4, 127.9, 125.4, 114.6, 114.5, 56.0, 51.8, 51.2,
50.0, 41.2, 38.2, 35.9, 33.6, 30.6, 29.6, 28.6, 27.3, 25.5, 25.2, 24.9, 24.2,
24.0, 23.9, 12.8; MS (ESI) m/z (rel %) 343 [MNa+ + MeOH] (19),
311 [MNa+] (100), 297 (41); HRMS (ESI) calcd for C17H24N2O2Na
[MNa+] 311.1730, found 311.1734.
N-((rel-(1S,7S)-6-(((tert-Butyldimethylsilyl)oxy)methylene)-7-
((Z)-pent-3-en-1-yl)cyclohept-3-en-1-yl)methyl)-N-(cyano-
methyl)formamide (102). Following the procedure used to prepare
40, a solution of 101 (34 mg, 0.12 mmol) in DCM (2.5 mL) was
treated with TBDMSOTf (54 μL, 0.24 mmol) and i-Pr2NEt (62 μL,
0.35 mmol) for 18 h at rt to afford, after the usual purification using
silica gel saturated with Et3N (0 to 40% EtOAc in hexanes), one
geometrical isomer (as a mixture of rotamers) of 102 (22.5 mg, 47%)
of unidentified stereochemistry as a colorless oil: 1H NMR (300 MHz,
CDCl3) δ (ppm) 8.18 (s) and 8.01 (s) (1H), 6.07 (s, 1H), 5.85−5.70
(m, 1H), 5.61−5.27 (m, 3H), 5.05−4.94 (m), 4.33 (d, J = 17.5 Hz),
and 4.17 (d, J = 17.5 Hz) (2H), 3.34−3.20 (m, 2H), 3.13 (dd, J = 17.0,
6.5 Hz, 1H), 2.78−2.59 (m, 1H), 2.18−1.79 (m, 6H), 1.73−1.51 (m,
1H), 1.58 (d, J = 7.0 Hz, 3H), 1.34−1.18 (m, 1H), 0.92 (s, 9H), 0.12
(s, 6H); 13C NMR (75.5 MHz, CDCl3) only the major rotamer
reported δ (ppm) 162.5, 135.1, 130.2, 129.8, 126.4, 124.7, 119.5,
114.4, 50.1, 43.5, 39.6, 30.1, 28.7, 26.0, 25.6, 25.3, 24.5, 18.3, 12.9,
−5.3; MS (ESI) m/z (rel %) 457 [MNa+ + O2] (45), 425 [MNa+]
(100), 411 (18); HRMS (ESI) calcd for C23H38N2O2SiNa [MNa
+]
425.2595, found 425.2605.
rel-(1S,6S,10S)-8-(Cyanomethyl)-1-formyl-10-((Z)-pent-3-en-
1-yl)-8-azabicyclo[4.3.1]deca-3,8-dien-8-ium Trifluoro-
methanesulfonate (103). Tf2O (3.0 μL, 19 μmol) was added to a
solution of 102 (5.0 mg, 12 μmol) and DTBMP (7.6 mg, 37 μmol) in
DCE (0.7 mL) at rt. After 10 min, an additional portion of Tf2O (1.0
μL, 0.6 μmol) was added. 1H NMR analysis showed the formation of
the iminium ion 103: 1H NMR (300 MHz, CD2Cl2) characteristic
signals δ (ppm) 9.69 (s, 1H), 9.39 (s, 1H), 6.16−6.06 (m, 1H), 5.82−
5.66 (m, 1H), 5.60−5.50 (m, 1H), 5.42 (d, J = 17.5 Hz, 1H), 5.34−
5.29 (m, 1H), 5.22 (d, J = 17.5 Hz, 1H), 4.13 (dd, J = 17.0, 4.5 Hz,
1H), 3.82 (d, J = 17.0 Hz, 1H), 2.92−2.58 (m), 2.40−1.89 (m), and
1.67−0.83 (m) (13H).
Methyl rel-(1R,6S,11S,12S,15S)-4-Aza-11-((E)-3-(tert-butoxy)-
3-oxoprop-1-enyl)-3-cyanotetra-cyclo[9.3.1.04,15.06,12]penta-
dec-8-ene-2-carboxylate (105). t-BuOK (5.2 mg, 44 μmol) was
added to a solution of tert-butyl diethylphosphonoacetate (14.0 mg,
55.4 μmol) in THF (1.0 mL) at 0 °C. The mixture was stirred for 30
min at 0 °C; then a solution of 98α/β-CN (11.6 mg, 36.9 μmol) in
THF (1.0 mL) was added. The reaction mixture was stirred for 2 h at
0 °C. Saturated aqueous NaHCO3 was added at 0 °C. The usual
workup (EtOAc) and purification (5 to 30% EtOAc in hexanes) gave
three separable diastereomers 105 (11.7 mg, 77%) as a pale yellow oil:
Diastereoisomer 1: 1H NMR (300 MHz, CDCl3) δ (ppm) 6.86 (d, J =
16.5 Hz, 1H), 5.67 (d, J = 16.5 Hz, 1H), 5.61−5.55 (m, 2H), 4.30 (d, J
= 8.0 Hz, 1H), 3.74 (s, 3H), 3.37 (bs, 1H), 3.32 (d, J = 6.0 Hz, 1H),
3.28 (t, J = 6.0 Hz, 1H), 2.93 (dd, J = 14.0, 9.5 Hz, 1H), 2.81 (d, J =
15.5 Hz, 1H), 2.62−2.50 (m, 1H), 2.31−1.95 (m, 5H), 1.77−1.63 (m,
1H), 1.58−1.32 (m, 2H), 1.50 (s, 9H), 1.14−0.98 (m, 1H); 13C NMR
(75.5 MHz, CDCl3) δ (ppm) 170.4 (s), 166.1 (s), 154.3 (d), 128.6
(d), 124.8 (d), 121.1 (s), 120.3 (d), 80.6 (s), 64.4 (d), 58.1 (d), 55.2
(d), 54.3 (t), 52.4 (q), 41.0 (s), 38.5 (d), 37.8 (t), 36.4 (t), 36.3 (d),
34.1 (d), 28.1 (q), 27.7 (t), 18.7 (t); IR (film) ν (cm−1) 3023, 2957,
2922, 2876, 1735, 1709, 1644, 1206, 1151; MS (ESI) m/z (rel %): 435
[MNa+] (41), 413 [MH+] (80), 408 [MNa+ − HCN] (100); HRMS
(ESI) calcd for C24H33N2O4 [MH
+] 413.2435, found 413.2444.
Diastereoisomer 2: 1H NMR (300 MHz, CDCl3) δ (ppm) 6.84 (d, J =
16.5 Hz, 1H), 5.82−5.68 (m, 2H), 5.67 (d, J = 16.5 Hz, 1H), 4.12 (d, J
= 7.5 Hz, 1H), 3.75 (s, 3H), 3.08−3.00 (m, 3H), 2.91 (d, J = 5.0 Hz,
1H), 2.69−2.58 (m, 1H), 2.58 (dd, J = 16.0, 6.5 Hz, 1H), 2.36−2.26
(m, 2H), 2.16−1.83 (m, 5H), 1.55−1.41 (m, 1H), 1.49 (s, 9H), 1.38−
1.24 (m, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 173.1 (s),
166.2 (s), 154.5 (d), 128.5 (d), 128.1 (d), 120.5 (d), 117.7 (s), 80.6
(s), 65.3 (d), 57.7 (d), 57.7 (d), 52.6 (q), 52.3 (t), 40.5 (d), 40.0 (t),
38.6 (s), 37.3 (d), 35.5 (t), 34.9 (d), 28.4 (t), 28.2 (t), 28.1 (q); IR
(film) ν (cm−1) 3023, 2959, 2921, 2876, 1739, 1709, 1644, 1209,
1147; MS (ESI) m/z (rel %): 435 [MNa+] (100), 413 [MH+] (69);
HRMS (ESI) calcd for C24H32N2O4Na [MNa
+] 435.2254, found
435.2269. Diastereoisomer 3: 1H NMR (300 MHz, CDCl3) δ (ppm)
6.87 (d, J = 16.5 Hz, 1H), 5.65−5.59 (m, 2H), 5.64 (d, J = 16.5 Hz,
1H), 4.35 (d, J = 9.5 Hz, 1H), 3.75 (s, 3H), 3.40 (dd, J = 14.5, 8.5 Hz,
1H), 3.27 (dd, J = 9.0, 6.0 Hz, 1H), 3.15 (dd, J = 14.5, 6.5 Hz, 1H),
3.09−3.02 (m, 1H), 2.73−2.53 (m, 2H), 2.33−2.06 (m, 5H), 1.98 (bs,
1H), 1.78−1.56 (m, 2H), 1.48 (s, 9H), 1.56−1.41 (m, 1H); 13C NMR
(75.5 MHz, CDCl3) δ (ppm) 169.7 (s), 166.2 (s), 154.9 (d), 128.7
(d), 125.3 (d), 120.2 (d), 117.6 (s), 80.6 (s), 64.8 (d), 54.8 (d), 52.4
(d), 52.1 (q), 49.6 (t), 41.2 (s), 39.0 (t), 37.7 (d), 37.2 (d), 36.4 (t),
34.6 (d), 28.1 (q), 27.9 (t), 19.0 (t); IR (film) ν (cm−1) 3016, 2943,
2931, 2884, 1744, 1709, 1641, 1215, 1152; MS (ESI) m/z (rel %): 435
[MNa+] (25), 413 [MH+] (100), 408 [MNa+ − HCN] (35); HRMS
(ESI) calcd for C24H33N2O4 [MH
+] 413.2435, found 413.2447.
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Methyl rel-(1R,6S,11S,12S,15S)-4-Aza-11-((E)-3-(tert-butoxy)-
3-oxoprop-1-enyl)tetracyclo[9.3.1.04,15.06,12]pentadeca-2,8-
diene-2-carboxylate (1016). A solution of 105 (19.2 mg, 46.5
μmol) in toluene (2.0 mL) was added to a solution of NaH (60% in
mineral oil, 93 mg, 2.3 mmol) in toluene (3.0 mL) at 0 °C. Then, the
mixture was refluxed for 12 h. Water was added at 0 °C. The usual
workup (EtOAc, washed with brine) and purification (0 to 30%
EtOAc in hexanes) afforded 105 (14.9 mg, 83%) as a colorless oil: 1H
NMR (300 MHz, CDCl3) δ (ppm) 7.11 (s, 1H), 7.09 (d, J = 16.0 Hz,
1H), 5.76 (d, J = 16.0 Hz, 1H), 5.66−5.47 (m, 2H), 3.98 (d, J = 10.0
Hz, 1H), 3.65 (s, 3H), 3.58 (dd, J = 14.0, 10.5 Hz, 1H), 3.33 (dd, J =
14.0, 9.0 Hz, 1H), 3.11 (t, J = 7.5 Hz, 1H), 2.63 (d, J = 16.5 Hz, 1H),
2.44 (dt, J = 18.5, 6.0 Hz, 1H), 2.35−2.19 (m, 2H), 2.12−1.91 (m,
3H), 1.72−1.56 (m, 1H), 1.49 (s, 9H), 1.43−1.23 (m, 1H), 1.13 (dd, J
= 14.5, 3.0 Hz, 1H); 13C NMR (75.5 MHz, CDCl3) δ (ppm) 166.5
(s), 166.4 (s), 154.8 (d), 153.0 (d), 131.2 (d), 122.9 (d), 118.9 (d),
104.6 (s), 80.4 (s), 65.4 (d), 50.4 (q), 50.0 (t), 42.0 (s), 40.3 (d), 40.0
(d), 38.5 (t), 34.7 (t), 34.3 (d), 28.2 (q), 26.1 (t), 23.7 (t); MS (ESI)
m/z (rel %): 408 [MNa+] (100), 386 [MH+] (20); HRMS (ESI) calcd
for C23H31NO4Na [MNa
+] 408.2145, found 408.2161.
tert-Butyl rel-(1R,2S,6S,11S,12S,15S)-4-Aza-2-(hydroxy-
methyl)tetracyclo[9.3.1.04,15.06,12]pentadecane-11-propanoate
(107). A solution of 106 (12.4 mg, 32.1 μmol) and Pd/C (10%, 3.4
mg, 10 mol %) in MeOH (1.5 mL) was stirred under a hydrogen
atmosphere (50 psi) for 36 h. The mixture was filtered on Celite and
concentrated under reduced pressure to afford the corresponding
saturated compound (12.6 mg, quantitative) as a colorless oil: 1H
NMR (300 MHz, CDCl3) δ (ppm) 3.67 (s, 3H), 3.48−3.36 (m, 1H),
3.21 (dd, J = 11.0, 8.0 Hz, 2H), 3.00 (dd, J = 15.0, 8.0 Hz, 1H), 2.84 (t,
J = 12.5 Hz, 1H), 2.72 (bs, 1H), 2.66−2.58 (m, 1H), 2.53−2.40 (m,
1H), 2.29−2.14 (m, 3H), 2.00−1.53 (m, 10H), 1.51−1.33 (m, 3H),
1.45 (s, 9H), 1.30−1.17 (m, 1H); MS (ESI) m/z (rel %): 392 [MH+]
(100); HRMS (ESI) calcd for C23H38NO4 [MH
+] 392.2795, found
392.2808. The latter (12.6 mg, 32.1 μmol) was dissolved in THF, (2.0
mL) and a solution of LiBH4 (2.0 M in THF, 32 μL, 64 μmol) was
added at 0 °C. After 30 min, an additional portion of LiBH4 (2.0 M in
THF, 32 μL, 64 μmol) was added. The mixture was stirred for 14 h at
rt; then water was added. Solvent was removed under reduced
pressure, and saturated aqueous NaHCO3 was added. The usual
workup (EtOAc, Na2SO4) and purification (20 to 50% EtOAc in
hexanes) gave 107 (4.9 mg, 42%, 49% brsm) as a colorless oil: 1H
NMR (400 MHz, CDCl3) δ (ppm) 3.68−3.58 (m, 2H), 3.55 (dd, J =
10.5, 6.5 Hz, 1H), 3.28 (dd, J = 15.0, 11.0 Hz, 1H), 3.20 (d, J = 3.5 Hz,
1H), 3.12 (t, J = 11.5 Hz, 1H), 2.88 (dd, J = 15.0, 9.5 Hz, 1H), 2.72−
2.48 (m, 3H), 2.21 (dd, J = 9.0, 8.0 Hz, 2H), 2.13−2.04 (m, 1H),
1.86−1.64 (m, 7H), 1.60−1.40 (m, 8H), 1.44 (s, 9H); 13C NMR (100
MHz, CDCl3) δ (ppm) 173.7 (s), 80.5 (s), 72.8 (d), 67.8 (t), 59.7 (t),
58.4 (t), 42.6 (d), 37.0 (d), 36.2 (s), 35.1 (t), 34.1 (d), 33.0 (d), 32.6
(t), 32.2 (t), 28.8 (t), 27.8 (q), 25.2 (t), 24.0 (t), 23.9 (t), 15.2 (t); IR
(film) ν (cm−1) 3448, 2975, 2932, 2878, 1725, 1478, 1455, 1152; MS
(ESI) m/z (rel %): 364 [MH+] (100); HRMS (ESI) calcd for
C22H38NO3 [MH
+] 364.2846, found 364.2862.
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